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The vertebrate pSer/pThr-Pro specific peptidyl-prolyl isomerase Pin1 has been 
shown to play important roles in cell cycle regulation, apoptosis, oncogenesis, and 
neuronal degeneration. However, its role in early neuronal development is not clear.  
With the use of zebrafish embryos, we examined zPin1’s effect on development. We 
showed that zebrafish Pin1 was expressed maternally and in a ubiquitous manner 
early in development, but by 48 hpf it was restricted to the brain and neuromasts. Co-
immunoprecipitation assays (CoIP) in cell lines showed that zPin1 could interact with 
neuroD and ath1 but not ngn1. This binding was reduced when Ser/Thr 
phosphorylation sites were mutated. Antisense morpholino oligonucleotide (MO) 
knockdown of zPin1 led to delay in development. Accounting for the delay, neuroD 
expression was significantly diminished in the hindbrain of morphants by 48 hpf 
equivalent. Morphants in the background of Tol2/GFP enhancer trap lines with 
specific expressions in hair cells (ET4) and mantle cells (ET20) also displayed defects 
in neuromasts formation. It has been shown that specification of hair cells in 
neuromasts is neuroD dependent but ngn1 independent. Using siRNA Pin1 
knockdown 293T cells and Pin1 knockout MEFs cells, we showed that neuroD 
protein was degraded more rapidly in the absence of Pin1. NeuroD stability was 
restored when Pin1 was over-expressed. This is the first study to demonstrate the 
functional regulation of a bHLH factor by cis-trans isomerization in neuronal 
specification. In view of the role of Pin1 in neurodegenative diseases, our results may 
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                         Chapter 1 Introduction 
1.1 The function of Pin1 
1.1.1 The relationship between Pin1 and protein phosphorylation  
Protein phosphorylation is one of the most essential signaling modes for post-
translational modification. The main effect of protein phosphorylation is to induce 
changes in protein conformation, which then further affects protein-protein 
interaction, subcellular localization and dephosphorylation (Blume-Jensen et al., 
2001; Pawson et al., 2005). Therefore, it is valuable for us to study molecules 
related to conformation changes induced by protein phosphorylation.     
Serine or threonine residues preceding proline (Ser/Thr-Pro) motifs are exclusive 
phosphorylation sites for many key protein kinases that play essential roles in cell 
proliferation and signal transduction. These kinases include cyclin-dependent protein 
kinases (CDKs), mitogen-activated protein kinases (MAPKs), extracellular signal-
regulated kinases (ERKs), N-terminal protein kinases (JNKs), glycogen synthase 
kinase-3 (GSK-3) and Polo-like kinase (PLKs). This group of phosphorylation 
depends on the presence of Pro residues that immediately follow Serine or 
Threonine residues; therefore, it is also called Pro-directed phosphorylation, 
indicating an essential role of Proline residues (Blume-Jensen et al., 2001; Nigg, 
2001; Lu, 2004; Pawson et al., 2005). Proline residue is unique among all amino 
acids due to its five-membered ring in its backbone. Usually, the other amino acids 
overwhelmingly adopt trans conformation (99%) because of the free energy 
consideration (Pal et al., 1999). However, when it comes to Proline residue, both 
trans (70-90%) and cis (10-30%) conformation exist due to its structural constraints 
(Brandts et al., 1975; Grathwohl et al., 1976; Juy et al., 1983). The transition 
between cis and trans conformation is called isomerization. This transition process 
Introduction 
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is rather slow if it happens spontaneously. With help from one enzyme family called 
cis/trans peptidyl-prolyl isomerase (PPIase), this process can be accelerated greatly 
(Hunter, 1998; Fischer et al., 2003). Until now, three PPIase family members have 
been identified. Among them, cyclophilins (Cyps) and the FK506-binding proteins 
(FKBPs) catalyze conformation changes of Serine/Theronine-Proline (Ser/Thr-Pro) 
motifs, independent of phosphorylation (Harding et al., 1989; Fischer et al., 2003). 
Only the third family member, parvuline can specifically catalyze conformation 
changes of a subset of phosphorylated proteins (Ranganathan et al., 1997; Yaffe et 
al., 1997). Human Pin1 (protein interacting with NIMA) and Pin1-like parvulines 
are considered novel members of parvuline and catalyze only phosphorylated 
Ser/Thr-Pro motifs in proteins so as to influence various cellular aspects such as cell 
growth, genotoxic stress, germ cell development and neuron differentiation. 
Deregulation of Pin1 is involved in various pathological conditions: cancer, 
Alzheimer’s disease and asthma (Lu, 2004; Etzkorn, 2006; Goutagny et al., 2006; 
Balastik et al., 2007; Yeh et al., 2007). The model of Pin1-catalyzed isomerization is 









Figure 1.1 Prolyl isomerization catalyzed by peptidyl-prolyl cis/trans isomerases 
(PPIases). Ser/Thr-Pro motif is a key regulatory phosphorylation motif in cells. Due to the 
presence of Pro residue, there is a large energy barrier for motif to have spontaneous 
isomerization. However, this isomerization can be greatly accelerated by PPIases. The 
function of PPIases is to change conformation of Ser/Thr-Pro motif from cis to trans or trans 
to cis. There are two conventional PPIases-cyclophilins and FKBPs which are 
phosphorylation-independent enzymes. (a) They can only catalyze isomerization of Xxx-Pro 
motifs, where Xxx indicates any amino acid except pSer or pThr. (b) Pin1 belongs to the third 
family of PPIases. It is the only known phosphorylation-dependent enzyme to change the 
conformation of pSer/Thr-Pro. Recent studies indicate that the cis and trans isomers of many 
proteins have distinct functions, and their conversions by PPIases can function as a new 









1.1.2 The characteristics of Pin1 
Pin1 was first identified in 1996 in yeast using yeast two-hybrid system for its 
ability to interact with the key mitotic kinase NIMA (Never In Mitosis A) and inhibits 
its mitosis-promoting activity (Osmani et al., 1991; Pu et al., 1995; Lu et al., 1996). 
Pin1 has been found to be evolutionarily conserved among eukaryotes (Zhou et al., 
1999; Huang et al., 2001; Metzner et al., 2001).  
Pin1 is an 18 kDa protein with two domains: N-terminal WW domain (named after 
two invariant Trp residues, amino acids 1-39) and C-terminal PPIase domain (amino 
acids 45-163) (Lu et al., 1996). WW domain acts as a binding module to bind its 
substrate via phosphoserine or phosphothreonine-proline motifs in its substrates. From 
structural and functional stuides, four amino acids of the WW domain including Ser16, 
Arg17, Tyr23 and Trp34 are responsible for its binding ability (Yaffe et al., 1997; 
Zhou et al., 2000; Wintjens et al., 2001). C-terminal PPIase domain is the catalytic 
domain to isomerize conformational changes of specific pSer/Thr-Pro motifs (Lu et 
al., 1996). In the PPIase domain, Lys63, Arg68 and Arg69 play an essential role for 
its catalyzing ability (Ranganathan et al., 1997; Yaffe et al., 1997). A Pin1 structural 
model is illustrated in Fig. 1.2.  
Since the discovery of Pin1, its function in biological processes such as cell cycle 
regulation, transcription, protein stability and pathological conditions including 
oncogenesis, apoptosis, neuron degeneration as well as development have been 









Figure 1.2 Overall architecture of human Pin1. X-ray structure of human Pin1 complexed 
with dipeptide Ala-Pro. Pin1 contains two domains: N-terminal WW domain and C-terminal 
PPIase domain. The two domains are connected by a flexible linker. WW domain consists of 
a tripel-stranded anti-parallel β sheets.  PPIase domain has four β sheets as well as four α 
helices. A sulfate ion is sequestered by a conserved basic cluster consisting of Arg68 and 
Arg69 in close proximity to the β methyl group of the Ala residue in the bound Ala-Pro 
dipeptide. (This figure was adapted from Lu et al., 2002). 
 
 
1.1.3 Pin1 function in cell cycle and cancer 
1.1.3.1 Pin1 function in M phase  
NIMA kinase is the key mitotic kinase in Aspergillus nidulans. The early study in 
Aspergillus nidulans and later study in eukaryotic organisms both indicate that NIMA 
kinase is essential for cells entering mitosis and inactivation of NIMA is required for 
exit from mitosis (Osmani et al., 1988; Osmani et al., 1991; Fry et al., 1995; Lu et al., 
1996). Based on these findings, Lu et al. hypothesized that Pin1 could play an 
important role in cell cycle regulation especially in mitosis.  Many studies have been 
carried out to test this hypothesis.  
Introduction 
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Lu et al. first gave evidence that depletion of Pin1 in budding yeast and tumor 
HeLa cells caused mitotic arrest (Lu et al., 1996; Rippmann et al., 2000). Meanwhile, 
overexpression of Pin1 in HeLa cells and Xenopus blocked cells in G2 by preventing 
cells from entering mitosis (Crenshaw et al., 1998; Shen et al., 1998). These results 
suggested a crucial role of Pin1 in mitotic regulation. More specifically, data indicated 
that Pin1 functions as a negative regulator for mitosis entry and is also required for 
exit from mitosis (Lu et al., 1996).  
Thus far, many mitosis substrates of Pin1 have been identified. These substrates 
include a large number of mitotic phosphoproteins such as Cdc25C, Plk1, Myt1, 
Wee1 and Cdc27C. These substrates are also recognized by phosphospecific mitosis 
marker MPM-2 antibody, suggesting that Pin1 must function essentially in mitosis 
phase (Yaffe et al., 1997; Crenshaw et al., 1998; Shen et al., 1998). 
Further studies have been carried on to study details about Cdc25C, Wee1, 
Topoisomerase (TopoIIα) and early mitotic inhibitor-1 (Emi1). Cdc25C is an 
phosphatase to activate an essential mitotic kinase Cdc2. Cdc25C itself needs to be 
phosphorylated by mitosis-specific proteins for activation. Pin1 thus interacts with 
phosphorylated Cdc25C to affect its activity to prevent premature entry into mitosis 
(Crenshaw et al., 1998; Shen et al., 1998). Pin1 can also facilitate dephosphorylation 
of Cdc25C by phosphatase PP2A (Zhou et al., 2000; Stukenberg et al., 2001). The 
inhibitory kinase responsible for phosphorylating Cdc2 is Wee1. Wee1 has to be 
downregulated after entering mitosis to release inhibitory effect on Cdc2. Pin1 helps 
to inactivate Wee1 at M phase (Okamoto et al., 2007).  
Emi1 is an early mitotic inhibitor-1 which prevents activation of cyclin A and B by 
anaphase-promoting complex (APC) at G2 phase to guarantee the entry of S and M 
phases at correct time. The binding of Pin1 with Emi1 stabilizes Emi1 and helps to 
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inhibit cyclin A and B proteins. Therefore, cells can enter S and M phase smoothly 
(Bernis et al., 2007).  
Mitotic phosphorylated TopoIIα can also interact with Pin1. This binding localizes 
Pin1 on chromatin and promotes chromatin condensation. Moreover, TopoIIα 
phosphorylation and binding ability to DNA are both increased due to Pin1 
association (Xu et al., 2007). Collectively, these findings indicated that Pin1 might act 
as a switch from G2 to M phase to guarantee progression of cell cycle.  
1.1.3.2 Pin1 function in G1 and S phase   
It is revealed that Pin1-/- mouse embryonic fibroblasts (MEFs) lose their capability 
to enter G1 and S phase from G0 phase of cell cycle (Fujimori et al., 1999). 
Furthermore, Pin1 knockout mice display defects in primordial germ cells which 
result from extended S phase (Atchison et al., 2003). These discoveries suggest that 
Pin1 is involved in G0/G1-S transition process.  
Accumulating evidence indicated that Pin1 functions essentially in G1/S transition. 
The best known substrate in this process is cyclin D1 which is a key regulator of G1/S 
progression (Ryo et al., 2001; Wulf et al., 2001; Liou et al., 2002). The first evidence 
to confirm function of Pin1 in G1/S transition is phenotypes of Pin1 knockout mice. 
Those mice display many severe phenotypes, including decreased body weight, retinal 
degeneration, mammary gland retardation and testicular atrophy. Most of these 
phenotypes are remarkably similar to those of cyclin D1-deficient mouse phenotypes. 
Afterwards, it has been reported that Pin1 can increase cyclin D1 mRNA level and 
protein expression through several pathways. Firstly, Pin1 can bind phosphorylated c-
Jun to enhance its transcriptional activity towards cyclin D1 promoter via AP-1 
binding site on the promoter region. This upregulation of transcriptional activity is 
further potentiated by cotransfection of Ras or JNK (Whitmarsh et al., 1996; Wulf et 
Introduction 
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al., 2001). Secondly, Pin1 enhances cyclin D1 mRNA level through β-catenin. β-
catenin is an important oncogenic transcriptional activator that can be regulated by 
tumor suppressor adenomatous polyposis coli protein (APC). APC binds β-catenin to 
form a complex and keeps β-catenin in cytoplasm for ubiquitin-mediated degradation 
(Polakis, 2000). Pin1 binds phosphorylated β-catenin to prevent its interaction with 
APC and thus affects degradation of β-catenin. The consequence is that Pin1 can 
accumulate more β-catenin in nucleus and increase its transcriptional activity towards 
its most important downstream target: cyclin D1 (Ryo et al., 2001). Thirdly, Pin1 also 
plays its role in regulating NF-κB (a heterodimeric complex of p50 and p65/RelA) 
signaling pathway. It has been characterized that Pin1 specifically binds to p65 
subunit of NF-κB. This association of Pin1 with p65 disrupts binding of NF-κB 
inhibitor (IκBα) with p65 to decrease degradation of NF-κB (Ryo et al., 2003). As a 
result, NF-κB becomes more stable and its transcriptional activity as well as the level 
of downstream target: cyclin D1 is increased. Lastly, Pin1 can directly bind and 
stabilize cyclin D1 (Liou et al., 2002).   
Besides cyclin D1, Pin1 modulates another two essential proteins implicated in 
G1/S phase and they are cyclin E as well as c-Myc. Pin1 can bind both cyclin E and c-
Myc and negatively regulate them by promoting their degradation through recruiting 
E3 ubiquitin ligase FBXW7 (Yeh et al., 2004; van Drogen et al., 2006; Yeh et al., 
2006).  
Pin1 is also involved in S phase centrosome duplication. Centrosome functions to 
segregate duplicated chromosomes to ensure proper cell division and cytokinesis. 
Duplication of centrosome begins at G1/S transition and is complete during S phase 
before mitotic phase (Doxsey et al., 2005). It was revealed that Pin1 is localized to 
centrosome and its expression level is correlated with centrosome amplification. 
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Detailed investigation shows that loss of Pin1 delays centrosome amplification; while 
overexpression promotes centrosome amplification (Suizu et al., 2006). These results 
indicate that Pin1 plays its role in S phase by affecting centrosome duplication 
without disturbing DNA synthesis.  
1.1.3.3 Pin1 function in oncogenesis 
Pin1 expression level is found to be increased in various kinds of cancers. As early 
as in 2001, it was reported that Pin1 expression level was upregulated in human breast 
cancer (Wulf et al., 2001). In prostate cancer, Pin1 expression level is an indicator of 
clinical stage and has prognostic value (Ayala et al., 2003). Later, Bao et al. carried 
out an extensive study in 2004 to investigate relationship between Pin1 expression 
and occurrence of tumors. For this study, 38 types of cancers such as breast, prostate, 
lung (60 types altogether) had phenomenon (around 10%) of Pin1 overexpression 
compared with normal healthy tissues (Bao et al., 2004). The molecular mechanism 
raveling Pin1’s implication in cancer will be described below.  
From sequence analysis, it has been revealed that Pin1 has three E2F binding sites 
and is subjected to E2F transcriptional regulation (Ryo et al., 2002). This finding is 
valuable when we try to link Pin1 expression with cancer. Given the crucial role of 
E2F/Rb deregulation in oncogenesis, it may be critical to upregulate Pin1 expression 
level (Macleod, 1999). Pin1 overexpression can enhance transformed phenotypes 
induced by oncogenic E2F upstream regulators Ras or Neu. Correspondingly, 
depletion of Pin1 can suppress transformed phenotype (Ryo et al., 2002). 
It was reviewed previously that Pin1 can regulate essential oncogene cyclin D1 
from multiple oncogenic signaling pathways. Not only deregulation of cylcin D1, but 
also centrosome defects and resulting chromosome instability by Pin1 overexpression 
have been suggested to play an important role in oncogenesis (Suizu et al., 2006).  
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Although a great number of findings demonstrate that Pin1 has a positive role in 
tumor formation, there are publications to show that loss of Pin1 can indeed lead to 
oncogenesis. Supporting evidence comes from Pin1 knockout MEFs, in which cylcin 
E and c-Myc are more stable due to Pin1’s stabilizing effect (Yeh et al., 2004; Yeh et 
al., 2006). Deregulation of both proteins is involved in tumor formation (Nesbit et al., 
1999). In addition, those Pin1 knockout MEFs cells have increased genomic 
instability and after p53 inactivation, they are more sensitive to Ras-induced 
transformation leading to the hypothesis that Pin1 possibly acts as a conditional tumor 
suppressor (Yeh et al., 2006; Yeh et al., 2007). Therefore, Pin1 may have a role in 
tumorigenesis either positively or negatively depending on background.  
 
1.1.4 Pin1 function in apoptosis 
Depletion of Pin1 was reported to lead to mitotic arrest and apoptosis in HeLa cells 
and budding yeast. Several interactors of Pin1 related to apoptosis have been 
identified. Pin1 can interact with apoptotic related proteins such as Bcl-2 to play a 
role in apoptosis process. Bcl-2 belongs to anti-apoptotic protein family; Bcl-2 is 
phosphorylated after treatment with microtubule-targeting drugs. This 
phosphorylation suppresses anti-apoptotic function of Bcl-2, resulting in an 
enhancement of apoptosis in cells. Pin1 can bind to phosphorylated Bcl-2 and further 
modulate its protein conformation, which may enhance dephosphorylation of Bcl-2, 
resulting in recovering to its non-phosphorylated state (Pathan et al., 2001; Basu et al., 
2002).  
The apoptotic function of p53 is inhibited by one of the most conserved inhibitors 
iASPP. iASPP binds to proline-rich domain of p53, thereby preventing binding of p53 
to cell death-related promoters (Bergamaschi et al., 2006). Pin1 binds to p53 and 
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promotes its dissociation from iASPP. Thereby, Pin1 facilitates p53-dependent 
apoptosis (Mantovani et al., 2007).  
Survivin is a G2/M phase marker during cell cycle (Li et al., 1998). Also, it is a 
member of Inhibitor of Apoptosis Protein (IAP) family acting to inhibit apoptosis 
(Altieri, 2006). It has been shown that although Pin1 can not interact directly with 
survivin, Pin1 can induce a decrease of survivin protein level. Pin1’s modulation on 
survivin level can be partly attributed to ubiquitin-proteasome pathway (Dourlen et al., 
2007). The death-associated protein Daxx is a Fas-interacting protein that specifically 
binds to death domain of Fas and then facilitates Fas-mediated apoptosis (Yang et al., 
1997). It has been reported that Pin1 acts against apoptosis response induced by Daxx. 
The mechanism is that Pin1 can promote ubiquitin-proteasome mediated degradation 
of Daxx via its interaction with phosphorylated Ser178 motif (Ryo et al., 2007). 
However, a recent paper showed that in mitochondria membrane of neurons, Pin1 
can bind and stabilize phosphorylated BIMEL, which was BH3-only protein triggering 
apoptosis in neurons in phosphorylated form, thereby Pin1 can promote neuronal 
apoptosis (Putcha et al., 2003; Becker et al., 2004; Becker et al., 2006) .This study 
provides a novel finding regarding the role of Pin1 in activating the mitochondrial 
apoptosis machinery specifically in neuron cells. An apoptosis model with Pin1 has 
been proposed (Becker et al., 2007).   
 
1.1.5 Pin1 function in Alzheimer’s disease 
Expression level of Pin1 in neurons is higher than other tissues in mouse. There is 
evidence to show that Pin1 expression is induced upon neuron differentiation (Lu et 
al., 1999; Hamdane et al., 2006). These hints prompted scientists to investigate Pin1’s 
neuronal function using Pin1-null mice. Those mice develop age-dependent motor 
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and behavioural deficits, demonstrated by abnormal limb-clasping reflexes, hunched 
postures, reduced mobility and eye irritation (Liou et al., 2003). They also display 
retinal atrophy which is one of the characteristics of neurodegeneration. Indeed, Pin1-
/-
 mice show age-dependent neurodegeneration (Liou et al., 2003). The degeneration 
is possibly caused by accumulation of MPM-2 epitopes, which is a common feature of 
Alzheimer’s disease (AD) (Preuss et al., 1998). Further study reveals that Pin1 knock 
out phenotypes resemble those induced by tau transgenic mice (Lewis et al., 2000; 
Lewis et al., 2001; Allen et al., 2002). Moreover, Pastorino et al. reported that in 
Pin1-/- mice, production of Aβ42 can be increased in an age-dependent manner, 
suggesting that Pin1 may regulate APP processing (Pastorino et al., 2006).  
There are two main characteristic pathological markers for Alzheimer’s disease: 
extracellular senile plaques and intracellular neurofibrillary tangles (NFTs). Senile 
plaques are mainly composed of β-amyloid peptides (Aβ) which are derived from 
amyloid precursor protein (APP) (Hardy et al., 2002). Tangles are made up of 
microtubule-associated protein tau that is aberrantly phosphorylated in Alzheimer’s 
disease (Spillantini et al., 1998). Accumulating evidence reveals that Pin1 can be 
involved in regulation of both APP and tau in Alzheimer’s disease (AD) (Zhou et al., 
2000; Akiyama et al., 2005; Pastorino et al., 2006).These two mechanisms will be 
discussed  separately in the following sections.  
APP can be cleaved in two ways based on different working secretases. One is 
called non-amyloidogenic pathway and the other one is amyloidogenic pathway. As is 
shown by names, beneficial and neurotrophic protein αAPP will be produced through 
α-and γ-secretases for non-amyloidogenic method, while harmful neurotoxic Aβ 
(mainly Aβ42) is generated by β- and γ-secretases in amyloidogenic pathway (Nunan 
et al., 2002). Following this, one question arises: how does APP choose a different 
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processing method? It turns out that APP in trans conformation is prone to being 
processed in non-amyloidogenic pathway and generates healthy αAPP, while for the 
cis conformation, APP adopts amyloidogenic method with products of harmful Aβ 
(Pastorino et al., 2006).  
APP tends to be in trans conformation when it is in non-phosphorylated state. In 
AD patients, APP tends to be phosphorylated on Thr668-Pro motif and 10% of 
protein adopts cis conformation after it has been phosphorylated (Ramelot et al., 2001; 
Lee et al., 2003). In this way, the equilibrium is built. With consumption of trans 
conformation protein to become αAPP, Pin1 functions to convert cis conformation 
protein to trans one. By doing so, Pin1 helps to avoid accumulation of too much cis 
APP protein as well as its toxic product (Pastorino et al., 2006). This kind of Pin1 
function got further support from results that Aβ product was reduced in the case of 
Pin1 overexpression while increased Aβ secretion for depletion of Pin1 (Pastorino et 
al., 2006).  
For NFTs, as mentioned, phosphorylated tau is the main component. Tau belongs 
to microtubule-associated proteins (MAPs) and it functions to stabilize microtubules. 
In AD brains, tau has been abnormally phosphorylated and hyperphosphorylated tau 
aggregates to become NFTs so that it can not attach to microtubule again. In other 
words, once tau is phosphorylated, its binding ability to microtubule and microtubule 
assembly both are abolished. Therefore, it is a critical issue in AD disease therapies to 
dephosphorylate tau. To examine Pin1's relationship with tau in AD disease, Lu et al. 
performed a series of experiments in 1999 (Lu et al., 1999). They screened all tau 
potential phosphorylation sites and finally found that Pin1 would bind tau when 
phosphorylation occured on Thr231 site in AD brain. This interaction induces 
conformational changes of tau to restore its biological function. The colocalization of 
Introduction 
 14 
Pin1 and tau also sequesters Pin1 in NFTs leading to accumulation of Pin1 in those 
neurofibrillary tangles and depletion of soluble Pin1 (Lu et al., 1999; Ramakrishnan et 
al., 2003). Moreover, Pin1 catalyzed prolyl isomerization facilitates tau 
dephosphorylation by PP2A in AD brains (Hamdane et al., 2006)  
Taken together, published data revealed association of Pin1 with both APP and tau. 










Figure 1.3 Pin1 catalyzed APP and tau processing in healthy and Alzheimer’s disease 
neurons. The trans conformation of phosphorylated (p) tau and APP represents the 
physiological conformation that promotes their normal function. (A) In Alzheimer’s disease, 
APP can be phosphorylated and the phospho-APP tends to adopt cis conformation and be 
cleaved via amyloidogenic pathway to produce toxic products of amyloid β-42 (Aβ42).  
Pin1 functions to convert cis to trans conformation of the phospho-APP, thereby, promote 
non-amyloidogenic APP processing and reduce Aβ production. This is similar for tau. (B) If 
tau is hyperphosphorylated in Alzheimer’s disease, it aggregates to form neurofibrillary 
tangles. The hyperphosphorylated tau is also resistant to protein phosphatase. Pin1 helps cis-
pTau to become trans-pTau that is accessible to phosphatase to recover the normal function 
of tau. Therefore, Pin1 deregulation might act on multiple pathways to contribute to AD 




1.1.6 Pin1 function in development 
Although Pin1’s function has been studied extensively, little is known about 
function of Pin1 in development. The characterized role of Pin1 in several model 
organisms has been presented in this section. 
In some organisms such as S.cerevisiae, C.albicans, and Aspergillus nidulans, 
current evidence indicats that Pin1 is indispensable for their growth (Lu et al., 1996; 
Devasahayam et al., 2002; Joseph et al., 2004). For example, as early as in 1996, Lu 
et al. showed that ESS1 (Pin1 homolog in yeast) was essential for yeast cell division 
and growth. They gave evidence that depletion of Pin1 in budding yeast and HeLa 
cells caused mitotic arrest and nuclear fragmentation in those cells (Lu et al., 1996; 
Wu et al., 2000). However, depletion of Pin1 in other species only displayed 
moderate defects. It has been revealed that in Drosophila, only defects in 
dorsalventral patterning of egg chamber appeared in Pin1/Dodo mutant. In detail, 
epidermal growth factor receptor (EGFR) signaling is determinant of dorsal follicle 
cell fate. Once it is activated, it will lead to a series of activation of 
Ras/Raf/MEK/MAPK and cause phosphorylation of a transcription factor CF2 in 
dorsal follicle cells. It has been well established that degradation of CF2 is vital for 
dorsal appendage patterning (Mantrova et al., 1998). In this process, Pin1/Dodo can 
interact with MAPK phosphorylated CF2 and enhance its ubiquitination as well as its 
subsequent degradation by proteasome (Hsu et al., 2001). However, Pin1 itself can 
not pattern egg chamber and it is just a responder to MAPK signaling.  
It has been reported that Pin1-null male and female mice are born with defective 
reproductive abilities and a reduced number of germ cells, suggesting Pin1 may play a 
very important role in regulating development of primordial germ cells (PGCs), which 
give rise to gonocytes and oocytes and eventual mature germ cells (Atchison et al., 
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2003). Therefore, Atchison et al. carried out experiment in 2003 to investigate role of 
Pin1 in PGCs proliferation. Pin1 has been found to impair proliferation of PGCs by 
prolonging cell cycle. As a result, fewer cell divisions occured and the number of 
PGCs was reduced. This reduction of PGCs during embryogenesis is the initial step 
followed by progressive age-dependent spermatogonia depletion in adult Pin1 knock 
out testis, resulting in complete loss of germ cells by 14 month of mice (de Rooij et 
al., 2000; Atchison et al., 2003). In summary, Pin1 is needed for spermatogonia 
proliferation and maintenance. However, the exact underlying mechanism remains to 
be elusive. A model regarding PGCs proliferation defects is shown below in Fig. 1.4.  
In vitro studies demonstrate that Ras/MEK/MAPK pathway can promote PGC 
proliferation and spermatogonial development (Dolci et al., 2001; De Miguel et al., 
2002). Indeed, Pin1/Dodo regulates MAPK phosphorylated CF2 to facilitate its 
ubiquitination. In addition, a study in C. albicans presents interaction of Pin1 with 
MAPK phosphorylated Ste12 to increase its transcriptional activity so as to influence 
filamentation process (Devasahayam et al., 2002). Taken together, it is possible that 
Pin1 regulates germ cell proliferation via acting on MAPK substrates (Atchison et al., 
2004). However, no further studies have been carried out to confirm role and 






      
 
Figure 1.4 Model of cell cycle defects for PGCs. There is no significant difference for the 
staining profile of Ki67 (all phases but absent in S phase), phosphohistone H3 (M phase) and 
apoptosis marker. However, Pin1-/- PGCs (bottom) have a lower BrdU labeling index. This 
result suggests that Pin1-/- PGCs do not display M phase arrest and apoptosis but show a 
prolonged cell cycle length due to defective cell cycle progression. Therefore, in the same 
time period until 13.5 dpc, fewer cell divisions (represented by arrows) occur in Pin1-
deficient PGCs, resulting in fewer PGCs in the absence of Pin1. (This figure was adapted 
from Atchison et al., 2003).  
 







1.1.7 Pin1 function on protein stability 
Pin1 has been demonstrated to be able to regulate stability of many proteins, either 
stabilize or destabilize. We will discuss this aspect carefully.  
1.1.7.1 The ubiquitin-proteasome pathway 
A majority of proteins is degraded through ubiquitin-mediated proteasome pathway. 
Ubiquitination process requires sequential actions of three enzymes (E1-E3). E1 is an 
activating enzyme that activates ubiquitin by forming ubiquitin-E1 thiol ester. E2, a 
conjugating enzyme, functions to carry ubiquitin by moving activated ubiquitin from 
E1. Subsequently, E3 ligase transfers ubiquitin to lysine residues on substrates. After 
several cycles, polyubiquitinated substrates are targeted for degradation in proteasome 
(Pickart 2001; Nandi et al., 2006). Here we discuss ubitquitin pathway because for 
some proteins, Pin1 affects their stability by interfering with this process.  
1.1.7.2 The role of Pin1 in protein stability 
A series of proteins can be stabilized by Pin1; these proteins include cyclin D1, β-
catenin, p53, p73, Mcl-1, NF-κB, BIMEL and Emi1. I will discuss how Pin1 regulates 
these proteins in details as follows.  
Cyclin D1 can be phosphorylated by GSK-3β on Thr286 and this phosphorylation 
facilitates its nuclear export to cytoplasm for degradation. Pin1 can interact with 
cyclin D1 through this Thr286 to prevent cyclin D1 export and accumulate it in 
nucleus for stabilization (Liou et al., 2002). In addition to cyclin D1, as described in 
section 1.1.3.2, Pin1 can specifically disrupt interaction between β-catenin and APC, 
resulting in decreased β-catenin turnover and increased nuclear distribution (Ryo et al., 
2001). 
As an essential tumor suppressor, p53 can be phosphorylated by MAP kinases and 
CDKs on Ser33, Thr81 and Ser315. Mdm2, as a binding partner and ubiquitin E3 
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ligase of p53, mediates degradation of p53. The interaction of Pin1 with p53 can 
abrogate association between p53 and Mdm2 and make p53 more stable (Zacchi et al., 
2002; Zheng et al., 2002).   
Emi1 is an inhibitor for APC to coordinate appropriate timing to activate APC and 
complete mitosis. Both cylcin B/cdk1 and Plx1 are reported to phosphorylate Emi1. 
Phospho-Emi1 is able to bind with βtrcp (one SCF) and is degraded via ubiquitin 
pathway. The interaction of Pin1 with Emil blocks Emil binding with βtrcp and thus 
makes it more stable (Bernis et al., 2007). 
When it comes to p73, the homologue to p53, it undergoes phosphorylation upon 
DNA damage. This phosphorylation favors Pin1 binding to p73 and promotes p73 
acetylation by p300 (Mantovani et al., 2004). Previously, it was reported that 
acetylation of p300 on p73 increases its stability (Oberst et al., 2005). Therefore, the 
ultimate function of Pin1 is to increase stability of p73.  
Myeloid cell leukemia sequence-1 (Mcl-1) belongs to anti-apoptotic Bcl-2 family 
member to block apoptosis under normal conditions. After spinal cord injury, JNK is 
activated to phosphorylate Mcl-1 and facilitate its degradation. In the absence of Mcl-
1, cytochrome C (cytC) is released to induce apoptosis in oligodendrocytes. Pin1 can 
stabilize Mcl-1 through interaction with pSer121 and pThr16 sites. The mechanism is 
to inhibit ubiquitination and degradation of Mcl-1 (Seo et al., 2007).  
BIMEL belongs to BH3-only family as an apoptotic molecule and is a vital factor to 
mediate apoptosis in neurons where apoptotic stimuli can activate JNK to 
phosphorylate BIMEL at Ser65 to promote apoptosis. Phosphorylation at Ser65 is 
known to lead to ubiquitin-dependent proteasome degradation. Pin1 can bind 




NF-κB is a transcription factor associated with cell proliferation, immune response 
and oncogenesis. NF-κB is sequestered and inhibited in cytoplasm by its inhibitor IκB. 
NF-κB is activated only when IκB is phosphorylated and degraded via ubiquitin-
mediated pathway. Pin1 can interact with pThr254-Pro motif on p65 subunit after 
cytokine treatment and inhibited association between p65 and IκB. This result is 
increased stability of NF-κB (Ryo et al., 2003). 
1.1.7.3 The role of Pin1 in protein destability 
The known proteins that can be destabilized by Pin1 include CF2, c-Myc, cyclin E, 
Che-1, PML, BTR and IRF-3. 
In Drosophila, CF2 is phosphorylated by MAPK on site Thr40 and then is 
degraded by ubiquitin-mediated pathway. Pin1 interacts preferentially with phospho-
CF2 to enhance its ubiquitination and degradation. Perhaps, the binding of Pin1 with 
CF2 changes its conformation and makes CF2 more accessible to ubiquitin (Hsu et al., 
2001).   
As a critical molecule, c-Myc has attracted much attention for the last decade. c-
Myc is first phosphorylated at Ser62 in response to growth stimuli. c-Myc in this state 
is stable and has high transcriptional activity. However, the ensuing phosphorylation 
at Thr58 makes c-Myc unstable (Sears et al., 2000; Dominguez-Sola et al., 2004). 
Pin1 can act to catalyze conformational changes of double phospho-c-Myc. The 
recognition of double phospho-c-Myc by Pin1 renders subsequent action of PP2A 
phosphatase to remove phosphate at Ser62. Thr58-phospho c-Myc is then degraded by 
ubiquitin-proteasome pathway. Therefore, Pin1 facilitates degradation of c-Myc 
(Dominguez-Sola et al., 2004; Yeh et al., 2004).  
The case of cyclin E is similar to c-Myc. Ser384 on cyclin E is subjected to 
phosphorylation by Cdk2 and this phosphorylation is a prerequisite for the later 
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SCFCdc4-dependent degradation. Pin1 binds cyclin E via this phosphorylated Ser384 
site and may facilitate its ubiquitylation and proteolysis via 26S proteasome (van 
Drogen et al., 2006).  
Che-1 is a human RNA polymerase II-binding protein to be involved in 
proliferation as well as apoptosis. Upon genotoxic signal, Che-1 is phosphorylated 
and downregulated by ubiquitin-dependent degradation. E3 ligase of Che-1 has been 
identified as Hdm2 (originally identified in mice as Mdm2). It has been demonstrated 
that interaction between Pin1 and Che-1 is required for Che-1 binding with Hdm2 and 
the following degradation (De Nicola et al., 2007).  
Promyelocytic leukemia protein (PML) is able to form PML nuclear bodies (PML-
NBs) to recruit various essential factors such as p53, Myc and CBP/p300. Interaction 
between Pin1 and phosphorylated PML results in degradation of PML. The suspected 
mechanism is that Pin1 may abrogate E3 ligase function for PML. It needs to be 
further assessed (Reineke et al., 2008).  
Pin1 can also facilitate degradation of Bruton tyrosine kinase (Btk) which is a non-
receptor tyrosine kinase. Although the mechanism has not been discovered, it has 
been confirmed this degradation has nothing to do with proteasome pathway (Yu et 
al., 2006).  
Interferon-regulatory factor 3 (IRF3) is an essential factor for immunity response. 
Upon response, it is activated and phosphorylated at Ser339. The subsequent binding 
of Pin1 to phosphorylated IRF3 promotes its polyubiquitination and proteasome-






1.1.8 The summary of Pin1 function 
The discovery of Pin1 provides a novel post-translational modification mechanism. 
As a cis/trans isomerase, Pin1 functions to interact with phosphorylated 
Serine/Threonine-Proline motifs (pSer/Thr-Pro) and catalyzes conformational changes. 
The result is to affect protein subcellular localization, protein-protein interaction and 
protein stability. As the consequence, Pin1 could have a profound effect on various 
cellular processes including cell cycle, apoptosis, neurodegeneration as well as germ 






Figure 1.5 A spectrum of target activities catalyzed by Pin1 isomerase. Pin1, belongs to 
peptidyl-prolyl isomerase (PPIase) family, targets on phosphorylated Ser/Thr-Pro motifs to 
greatly accelerate cis to trans or trans to cis isomerization. Therefore, Pin1-catalyzed prolyl 
isomerization can have a profound effect on its substrates. Indeed, Pin1 can influence protein 
localization, transcriptional activity, protein stability, protein interaction, catalytic activity as 
well as protein dephosphorylation of its targets. AlB1: amplified in breast cancer-1; BTK: 
Bruton’s tyrosine kinase; DAB2: disabled homologue-2; Emi1: early mitotic inhibitor-1; HBx: 
hepatitis B virus X-protein; IRF3: interferon-regulatory factor-3; MCL1: myeloid cell 
leukaemia sequence-1; PML: promyelocytic leukemia protein; STAT3: signal transducer and 
activator of transcription-3; TopoII, topoisomerase-II; TRF1: telomeric protein. Pin1 could 
increase stability of  cyclin D1, Emi1, p53, p73, β-catenin, MCL1, BIMEL, NF-κB as well as 
HBx. Meanwhile, Pin1 could facilitate degradation of CF-2, c-Myc, cyclin E, IRF3, BTK, 
Bax, TRF1, PML and Che-1. (This figure was adpated from Lu et al., 2007).  
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1.2 The function of NeuroD 
1.2.1 Introduction of bHLH factors 
Basic helix-loop-helix (bHLH) transcription factors are essential for determination 
and differentiation process in early embryonic development. One famous example is 
MyoD which is capable of converting embryonic cells into muscle tissues (Weintraub, 
1993).   
There are two classes of bHLH transcription factors: class A and B. Class A 
proteins are ubiquitously expressed and their members include E2, E12 and E47. 
These proteins function to form a complex with class B proteins which are tissue-
specific transcription factors such as MyoD and NeuroD. The complexes of class A 
and B proteins bind to a specific DNA sequence called E-box (CANNTG) to activate 
transcription of downstream target genes. However, another protein family, Id 
proteins (Inhibitor of differentiation) is well known for its ability to interact with 
general bHLH transcription factors. Id proteins are characterized by their HLH region, 
but lack DNA binding domain (Norton et al., 1998). This binding abolishes the ability 
of the complexes (ubiquitously expressed E proteins and tissue specific bHLH 
proteins) to interact with DNA (Benezra et al., 1990). Therefore, Id proteins are 






Figure 1.6 General interactions of bHLH proteins. A. Class A proteins are ubiquitously 
expressed E proteins that interact with tissue-specific bHLH proteins (class B proteins) to 
bind to E-box (green area) and activate downstream target genes. B. Inhibitory bHLH proteins 
(Id proteins) lack DNA binding domain could disrupt dimer formation, thereby impairing 
transcriptional activity of bHLH proteins. (This figure was adapted from Chae et al., 2004). 
 
1.2.2 Overview of NeuroD function 
   NeuroD was first identified in 1995 by a yeast two-hybrid experiment. The author 
carried out an assay to examine that overexpression of NeuroD was capable of 
converting non-neural ectoderm into neurons in Xenopus embryos, acting as a 
terminal differentiation factor (Lee et al., 1995). 
At about the same time, hamster homolog of NeuroD was isolated as a pancreatic 
beta-cell E box trans-activator 2 (BETA2) which regulated specific expression of the 
insulin gene in β-cells (Naya et al., 1995). This regulation was through binding of 
BETA2/E47 complex with E elements in insulin promoter.  
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More than 10 years passed since the discovery of NeuroD. Lots of studies have 
been carried on to investigate function of NeuroD in neuron differentiation and insulin 
gene regulation (Chae et al., 2004; Dufton et al., 2005; Seo et al., 2007; Gasa et al., 
2008). Besides, modification of NeuroD has been studied. We will review these 
aspects one by one. 
 
1.2.3 Phenotypes for NeuroD-null mice  
NeuroD-null mice die 3-5 days after birth due to severe hyperglycemia, which 
results from developmental and functional defects of pancreatic endocrine cells (Naya 
et al., 1997). In NeuroD-null mice, the number of insulin-producing β cells is shown 
to be reduced markedly and islet fails to form at birth, suggesting an important 
regulative function of NeuroD in islet development and insulin secretion (Naya et al., 
1997).  
To reveal more phenotypes in NeuroD-null mice, Miyata et al. rescued NeuroD-
null mice from neonatal hyperglycemia by introducing NeuroD specifically back into 
pancreas under control of the insulin promoter. By doing so, neuronal phenotypes of 
NeuroD-null mice can be viewed and characterized (Miyata et al., 1999).  
In mouse, otic placode develops between embryonic (E) day 9.5 and E15.5. 
Previous studies showed that ngn1 was essential for inner ear development, by the 
fact that ngn1 null mice failed to develop inner ear sensory neurons (Ma et al., 2000). 
On the other hand, development of inner ear hair cells is controlled by Math1 
(Mammalian atonal homolog) because the absence of Math1 causes loss of hair cells 
(Bermingham et al., 1999). Similarly, NeuroD-null mice also display deaf phenotype 
as evident by the absence of auditory evoked potential (AEP). The cause of this 
phenotype is loss of sensory neurons in inner ear (Kim et al., 2001). Later, it has been 
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claimed that NeuroD is necessary for both survival and differentiation of inner ear 
sensory neurons. Meanwhile, sensory neurons migration and ganglia fiber projection 
are also defective, indicating diverse roles of NeuroD in regulating sensory neuron 
development (Kim et al., 2001).  
Furthermore, histological examination of NeuroD-null mice reveals depletion of 
granule cells in both cerebellum and hippocampus. Such a phenotype indicates that 
NeuroD is critical for postnatal neurogenesis in mouse brain (Miyata et al., 1999).  
 
1.2.4 Protein interactors of NeuroD 
Acetylated histones are a hallmark for being in a transcriptionally active state of 
chromatin. Enzymes that catalyze acetylation reaction are called histone 
acetyltransfereases (HAT) and they are generally linked to transcriptional activation 
(Turner, 1993). p300 and closely related homolog protein CBP (p300/CBP) are well-
known transcriptional coactivators for regulating various transcriptional factors 
(Janknecht et al., 1996). It is also demonstrated that they have intrinsic histone 
acetyltransferease activity to modify chromatin structure into relaxed and 
transcriptional active state (Bannister et al., 1996; Ogryzko et al., 1996).  
It has been reported previously that p300/CBP acts to enhance transcriptional 
activity of NeuroD towards insulin genes. This increase is due to the direct interaction 
between NeuroD and p300 (Qiu et al., 1998; Sharma et al., 1999; Qiu et al., 2004). 
Cyclin D1, an important cell cycle regulator, can also bind with p300 and this binding 
can recruit cyclin D1 to the NeuroD-p300 complex. The consequence is that cyclin 
D1 negatively regulates transcriptional activity of NeuroD although cyclin D1 can not 
directly bind with NeuroD (Ratineau et al., 2002).  
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Id proteins are characterized by their helix-loop-helix (HLH) region, but lack DNA 
binding domain (Norton et al., 1998). Id proteins are dominant-negative regulators of 
bHLH proteins. So far, four isoforms (Id1-4) have been identified for this class of 
proteins. Ghil et al. showed that Id2 disrupted formation of BETA2-E47 complexes 
by directly interacting with E47 to inhibit transcription activity of BETA2 (Ghil et al., 
2002). In 2003, Liu et al. further demonstrated that Id2, Id3 and Id4 all can inhibit 
activity of NeuroD in Xenopus embryos (Liu et al., 2003).  
Several NeuroD binding partners have been identified by yeast two-hybrid 
screening, such as Six3 and small heterodimer partner (SHP). Six3 is a homeobox 
gene that functions essentially in the development of eye and forebrain. Six3 was 
revealed in Xenopus to coexpress with XneuroD or Xath5 during retina determination 
and differentiation stages, indicating that Six3 may have a role in retina development 
(Tessmar et al., 2002). SHP is an orphan nuclear receptor that lacks conventional 
DNA binding domain (DBD) (Seol et al., 1996; Lee et al., 2000). SHP acts as a 
transcriptional repressor of NeuroD by interacting with NeuroD. The interaction 
between SHP and NeuroD would compete with interaction between p300 and NeuroD. 
As a result, p300-enhanced transcriptional activity of NeuroD is significantly reduced 
(Kim et al., 2004). 
Huntington (Htt) protein is essential for neuronal development. Loss of Htt is the 
cause of Huntington’s disease. By using Huntington as the bait, yeast two-hybrid 
screening isolated huntington-associated protein (HAP1) and mixed–lineage kinase 2 
(MLK2) as binding partners of Htt protein (Li et al., 1995; Liu et al., 2000). In an 
experiment carried out by Marcora et al., it was found that NeuroD interacted with Htt, 
HAP1 and MLK2 in mouse neuroblastoma (N2A) cell line. Binding of NeuroD with 
HAP1 and MLK2 facilitated its binding with Htt. Meanwhile, it was also 
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demonstrated that MLK2 functioned to phosphorylate NeuroD and this 
phosphorylation stimulated transcriptional activity of NeuroD. The role of MLK2 was 
supported by Htt and HAP1 (Marcora et al., 2003). 
 
1.2.5 Post-translational regulation of NeuroD 
Phosphorylation of NeuroD has attracted more and more attention for its role in 
regulating transcriptional activity in respect to neurogenesis and insulin secretion.  




                        
 
    
Figure 1.7 Scheme of NeuroD protein. bHLH region (grey box) lies near N-terminal of 
protein. Ser257, Ser266 and Ser274 are phosphorylation sites of ERK. Furthermore, Ser274 
also lies within GSK3β consensus phosphorylation motif. CaMKII phosphorylation site 
Ser336 is also shown. (This figure was adapted from Chae et al., 2004).   
 
For function of NeuroD mediated insulin gene transcription activity in response to 
glucose, study in beta cell line MIN16 indicated that upon glucose stimulation, 
NeuroD tended to translocate from cytoplasm to nucleus. This kind of movement 
depended on phosphorylation by activated MEK-ERK signaling on its Ser274 but not 
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other potential serine sites (Ser162, Ser259 and Ser266). In this process, not only the 
location of NeuroD was changed but also NeuroD transcriptional activity has been 
increased (Petersen et al., 2002; Arnette et al., 2003).  
Detailed study carried out by Khoo et al. in 2003 revealed that phosphorylation of 
BETA2 by ERK2 enhanced BETA2’s ability to heterodimerize with E47/12 and bind 
to DNA and increase transcriptional activity of BETA2 in beta cells. This experiment 
result also demonstrated that the most significant phosphorylation site was Ser274 
while other sites such as Ser162, Ser159 and Ser266 were minor phosphorylation sites 
(Khoo et al., 2003). Ser274 site is affected most by phosphorylation maybe due to 
flanked consensus ERK phosphorylation sequence as revealed in Fig. 1.7.  
Marcus et al. performed experiments in Xenopus in 1998 to demonstrate that 
injection of GSK3β mRNA into Xenopus inhibited primary neurogenesis, with 
staining of N-tubulin as the marker (Chitnis et al., 1995; Marcus et al., 1998).  
Furthermore, they also showed that GSK3β functioned through inhibiting Ngn1 and 
NeuroD because coinjection of GSK3β together with ngn1 RNA or neuroD RNA 
completely abolished ectopic neurogenesis, while ngn1 or neuroD RNA itself can 
induce (Lee et al., 1995; Moore et al., 2002). However, it did not block ability of 
Ngn1 to activate neuroD exepression, suggesting that GSK3β may act downstream of 
neuroD to inhibit neuronal differentiation (Marcus et al., 1998). It is highly possible 
that this regulation is through GSK3β phosphorylation due to the presence of 
consensus and potential GSK3β phosphorylation motif in NeuroD (SPPLSV 274-279).  
Moor et al. demonstrated in 2002 that NeuroD was inhibited by GSK3β in Xenopus 
retina ganglion cells (RGC). It was tested that in Xenopus retinal neurons, 
overexpression of NeuroD facilitated differentiation of late-born amacrine cell type 
(Kanekar et al., 1997). Furthermore, both inhibition of GSK3β and S274A mutant of 
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NeuroD in retina resulted in relief of blocking and differentiation of early-born 
ganglion cell type (Moore et al., 2002). 
   Dufton et al. demonstrated that overexpression of X-NeuroD can convert epidermal 
precursors into neurons and induce abnormal neurogenesis by its own transcriptional 
activity. Both S266A or S274A mutant but not S259A enhanced its activity to form 
ectopic neurons. Furthermore, in injected Xenopus embryos, more S266A or S274A 
mutant protein was accumulated, providing a possible reason for increased ability to 
form ectopic neurons. In contrast, two mutants especially S274A decreased NeuroD 
activity towards insulin genes (Dufton et al., 2005). To conclude, phosphorylation can 
increase activity of NeuroD towards insulin gene transcription and decrease its 
neurogenesis ability. Therefore, NeuroD is regulated either positively or negatively 
through the same serine residues, depending on cellular context.  
In cerebellar granule neurons, calcium-calmodulin-dependent kinase CaMKII has 
been demonstrated to catalyze neuronal activity mediated phosphorylation of NeuroD 
at the site of Ser336. Phosphorylation at Ser336 would stimulate dendritic growth. 
However, this phosphorylation does not affect transcriptional activity of NeuroD. 
Hence, NeuroD’s function to promote dendritic growth is distinct from its role as a 
survival factor in differentiating cells (Gaudilliere et al., 2004).  
 
1.2.6 The upstream and downstream regulators of NeuroD 
Huang et al. carried out detailed analysis of neuroD promoter region to identify its 
cis and trans regulatory elements. A 2.2-kb (-2191 to +11) BETA2 promoter was 
analyzed. This region is sufficient to drive tissue-specific gene expression in 
pancreatic islets. Deletion mutation analysis from 2.2 kb to 231 bp reveals trans 
element between -2.2 to -1.0 kb region, while cis elements exist between -1.0 kb to -
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230 bp of promoter region. It turns out that three most proximal boxes (E1-E3, 
sequence is CANNTG) are the most critical DNA binding sites. Among them, Ngn3-
E47 complex binds with E1 and E3 to activate neuroD promoter (Miyachi et al., 1999; 
Huang et al., 2000). In this experiment, it has also been demonstrated that neuroD 
might have ability of autoregulation probably through E1 and E4 boxes.  
For neuroD upstream regulators, the most famous ones are neurogenin family 
genes. Three members are identified in this family: Ngn1, 2 and 3. A series of 
experiments reveal that all three members function upstream of neuroD. Neurogenin1 
was first identified in 1996. In situ hybridization expression analysis in mouse and 
Xenopus reveals that ngn1 expression precedes neuroD. Moreover, ectopic Xngn1 
expression leads to ectopic neurogenesis and induces endogenous neuroD expression 
in Xenopus but not vice versa (Ma et al., 1996; Ma et al., 1998). Ngn2 is essential for 
development of three cranial sensory ganglia that derive from epibranchial placode. In 
Ngn2 null mutant mice which exhibit defects in cranial sensory neurons, neuroD 
expression is absent. This result confirms the epistatic relationship between ngn2 and 
neuroD (Fode et al., 1998). Ngn3 predominantly affects pancreas islet development 
since mice carrying null mutation for ngn3 display the lack of islet cells (Gradwohl et 
al., 2000). Expression of ngn3 also precedes neuroD expression and later overlaps 
with neuroD during early islet cell differentiation. Detailed expression pattern of ngn3 
and other transcription factors in early pancreas islet cells suggests a model that place 
ngn3 upstream of neuroD in endocrine differentiation (Schwitzgebel et al., 2000).   
Another neuroD upstream regulator is insulinoma-associated antigen-1 (IA-1), 
which is a zinc-finger DNA-binding protein. Expression of IA-1 is linked with those 
pancreas-specific transcription factors. IA-1 is a negative regulator of neuroD, 
possibly through competing DNA binding site with ngn3 (Breslin et al., 2002). 
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Furthermore, in 2006 it was demonstrated that IA-1 co-operated with cyclin D1 and 
HDACs (histone deacetylases) to confer its transcriptional repressor activity (Liu et 
al., 2006).  
Several neuroD downstream targets have been identified. The most significant ones 
are pax4 and pax6. Pax genes are involved in development of a series of organs, such 
as eye, brain, kidney, pancreas and immune system (Chalepakis et al., 1993; Noll, 
1993).  
Other essential downstream targets of neuroD are a series of proteins including 
related to insulin expression: sulfonylurea receptor 1 (SUR1), β-glucokinase (βGK) 
and islet-specific glucose-6-phosphatase (G6Pase) catalytic-subunit-related protein 
(IGRP). All three proteins are expressed in β cells and are related to the release of 
insulin (Kim et al., 2002; Martin et al., 2003; Moates et al., 2003). For neuron 
differentiation function of NeuroD, characteristic targets of NeuroD are Xebf3 in 
primary sensory neurons and XBrn3d in retinal ganglion cells (Hutcheson et al., 2001; 
Pozzoli et al., 2001). Detailed analysis of neuroD downstream targets was performed 
in 2007. Results were listed in that paper (Seo et al., 2007).   
 
1.3 Advantages of zebrafish model  
Zebrafish is a small teleost fish and has emerged as one of the leading models to 
study development. Zebrafish provides many advantages as a development model. 
First of all, zebrafish embryos are transparent for easy visualization of tissues and 
organs. Secondly, productivity is very high to allow for a large-scale phenotypic 
screening. Thirdly, zebrafish develops rapidly and many organs are well developed by 
5 to 6 days post-fertilization (dpf). Lastly and the most important thing is that 
zebrafish, as a vertebrate organism, presents many organs and cell type similar to that 
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of mammals. But zebrafish is much simpler than mammals so that it is easier to study 
fish model first and then apply to human beings. In recent years, zebrafish has become 
a well-established model system and contributed to our understanding of 
developmental process (Rubinstein, 2003). 
  
1.4 Introduction of zebrafish lateral line 
1.4.1 Zebrafish lateral line developmental process  
Zebrafish lateral line is a mechanosensory organ for sensing environmental 
stimulus and vibration for behaviours such as predator avoidance and prey detection. 
The lateral line placode is derived from ectodermal placodes. After development, the 
lateral line placode comprises two parts: the anterior lateral line (ALL) and posterior 
lateral line (PLL), based on its relative position to otic placode (Metcalfe et al., 1985; 
Andermann et al., 2002; Dambly-Chaudiere et al., 2003).  
The PLL placode gives rise to stationary PLL ganglion which locates just posterior 
to ear and a migratory component that migrates along horizontal myoseptum to the tip 
of tail. Primordium migration begins at about 22 hours post fertilization (hpf), and by 
the end of embryogenesis until 48 h, it finally reaches the tip of tail. At this process, 
they deposit neuromasts-sensory organs at regular intervals (Metcalfe et al., 1985; 
Gompel et al., 2001). At 48 h, five neuromasts have been deposited along the lateral 
line and 2-3 terminal neuromasts on the tip of tail (Dambly-Chaudiere et al., 2003). 
Neuromasts are made up of three types of cells: central hair cells, inner accessory 
cells (support cells) and outer accessory (mantle) cells (Jones et al., 1993). The 
ganglion, neuromast structure and different cell types are illustrated in Fig. 1.8. 
Following this embryonic primary lateral line formation, development process 








Figure 1.8 Composition of zebrafish lateral line. (A) Scheme of overall structure of lateral 
line, illustrating innervation of ALL and PLL. Photograph shows organization of ALL and 
PLL projections in young larvae. ALL were labeled with dextran-fluorescein (green) and PLL 
were labeled with dextran-rhodamine (red) of head and body neuromasts, respectively. (B) 
Structure of a neuromast, illustrating different cell types that were involved and their 
organization.  The most important component of a neuromast is central localized 
mechanosensory hair cells which are surrounded by inner rim support cells and outer rim 
mantle cells. (This figure was adapted from Dambly-Chaudiere et al., 2003).  
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1.4.2 Genes involved in the formation of neuromasts and ganglion  
Hair cells in the lateral line share great similarities to those hair cells in vertebrate 
inner ear, indicating that maybe some of the same genes are implicated in 
differentiation and determination process (Kim et al., 1997). It has been reported 
previously that the mouse atonal homologue, math1, regulates sensory hair cells in 
mouse inner ear (Bermingham et al., 1999). In zebrafish, ath1 expression (zebrafish 
atonal homologue,) has been studied and it is expressed in hair cells specifically (Itoh 
et al., 2001). Later on, Sarrazin et al. did experiments to show that loss of function for 
either ath1 or nrd induced hair cells defects in neuromasts but not mantle cells. 
Together with in situ hybridization result that two genes were expressed specifically 
on neuromasts hair cells, authors got the conclusion that ath1 and nrd controlled 
determination and differentiation of hair cells (Sarrazin et al., 2006). The result that 
nrd can partially rescue those defects caused by ath1 MO provides evidence that nrd 
functions downstream of ath1 in hair cell development. 
However, it is not the case for formation of other neurons. The PLL ganglion 
formation depends on expression of ngn1 (Andermann et al., 2002). Andermann et al 
showed that in ngn1 loss of function embryos, ganglion was lost but neuromasts still 
existed, suggesting that ngn1 predominantly determined the presence of ganglion 
(Andermann et al., 2002).  
 
1.5 Objectives of this study 
As mentioned above, Pin1 has been reported to regulate function of a great number 
of proteins that are involved in diverse biological processes. Pin1 also has pivotal 
roles in cancer formation and is known to protect against neurondegenerative diseases. 
With the use of cancer cell lines and mouse models, these physiological and 
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pathological functions of Pin1 have been studied extensively. However, Pin1’s 
function in embryo development still remains elusive.  
Previously, it has been reported that Pin1 is a conserved enzyme in different 
biological systems (Lu et al., 1996). We therefore propose to study Pin1’s function in 
zebrafish since zebrafish is a leading model organism for developmental biology and 
has many advantages compared with other models in studying development. These 
advantages include transparency, high productivity and similarity to mammals 
(Rubinstein, 2003). Fish model is especially useful for neuron study. In mammals, 
central nervous system is quite complex and adds difficulties for detailed 
investigation. Zebrafish, in contrast, has been well-established for its neuron clusters 
in each part of brain, especially in spinal cord and hindbrain (Moens et al., 2002; 
Lewis et al., 2003). 
Therefore, in my thesis study, I focused to explore Pin1 functions in development 
process especially in neurons.  
Specific aims of my project were: 
1. To identify zpin1 genomic structure. 
2. To investigate zpin1 gene copy numbers in zebrafish.  
3. To examine zpin1 mRNA and protein expression pattern in zebrafish embryos. 
4. To characterize loss-of-function phenotypes of zpin1 using morpholino 
microinjection. 
5. To identify new binding partners of zpin1. 
6. To explore mechanism underlying zpin1’s regulation on new targets 
Pin1 is tightly correlated with Alzheimer’s disease and has become a potential drug 
target for therapy of Alzheimer’s disease. Considering this role of Pin1, our study is 
of vital significance to identify partners of Pin1 in neuron development.  
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                      Chapter 2 Materials and Methods 
2.1 Molecular technology 
2.1.1 Polymerase chain reaction (PCR) 
Specific sense and antisense primers of zpin1 were designed based on the database 
EST searching result. PCR was performed with zebrafish cDNA library as template. 
The reaction system adopted was 25 µl in total with 2.5 µl of 10 × PCR buffer, 0.5 µl 
of 2 U/µl Tag polymerase (Finnzymes), 0.5 µl of 10 mM dNTP, 0.5 µl of 10 mM of 
sense primer, 0.5 µl of 10 mM of antisense primer and 1 µl of template cDNA. 
Following an initial 5 min denaturation at 95 ˚C, 30 cyclys of PCR were done using 
the following condition: denaturing at 95 ˚C for 1 min, annealing at 55 ˚C for 1 min 
and extending at 72 ˚C for 1 min ending with an addition 10 min extension at 72 ˚C.   
zpin1 sense: 5’-ATATTAGAATTCATGTCCGACGACGAGAAGCTG-3’ 
zpin1 antisense: 5’-CAGTAATCTAGATTATCCGGTTCTCAAGATGAT-3’ 
 
2.1.2 PCR product purification 
PCR products were subjected to gel electrophoresis for analysis. Once target bands 
were identified, bands were recovered with QIAquick Gel Extraction Kit (Qiagen). 
Bands were cut from gel and melted at 50˚C by adding 3 volumes (relative to the band 
weight) of buffer QX1 (solubilization and binding buffer) for 15 min. The melting 
solution was loaded into the spin column and centrifuged at 13,000 × g for 1 min. 
Subsequently, the column was washed by adding 0.75 ml of buffer PE (wash buffer) 
followed by centrifugation. The flow-through was discarded and PCR products were 
eluted with 20-30 µl of sterile water or elution buffer (EB; 10 mM Tris-Cl, pH 8.5) by 
centrifugation at 13,000 × g for 1 min.  
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PCR products can also be retrieved directly by using QIAquick PCR Purification 
kit (Qiagen). 5 volumes of buffer PB (Binding buffer) was added to the PCR sample 
and the mixture was added to the spin column. The column was centrifuged at 13,000 
× g for 1 min and washed with 0.75 ml of buffer PE. After spinning for 1 min, PCR 
products were eluted with sterile water or buffer EB from the column.  
 
2.1.3 DNA ligation and transformation 
The purified PCR products were cloned into the pGEMT-vector system (Promega). 
The whole reaction volume was 10 µl, containing 1 µl of 10 × ligation buffer, 3 µl of 
purified PCR product, 0.5 µl of 50 ng/µl pGEMT-vector, 1 µl of 3 U/µl of T4 DNA 
ligase. The ligation solution was incubated at 16 ˚C for overnight. 
If the products were going to be ligated to the specific vector such as pCS2+, the 
products were recovered with gel extraction kit and then digested with two restriction 
enzymes (EcoRI and XbaI for zpin1) for about 3 h at 37 ˚C water bath. The digestion 
products were subjected to DNA gel electrophoresis and gel extraction. The same 
restriction enzyme digestion was performed for the pCS2+ vector. Once the inserts 
and the vector were both ready, the ligation reaction was assembled just as the 
pGEMT system.  
For the transformation, the ligation products were added into 100 µl of E .coli 
DH5α competent cells and incubated on ice for 30 min. The mixture was heated at 42 
˚C for 90 seconds and cooled immediately on ice for 5 min. Subsequently, 1 ml of LB 
medium was added to the tube and incubated at 37 ˚C for 1 h. After incubation, the 
solution was spinned down. The supernatant was thrown away with only about 30 µl 
of solution being left. The pellet was resuspended in the solution and was spread onto 
the LB plate supplemented with appropriate antibiotics. The plates were incubated at 
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37 ˚C overnight. The grown colonies were picked up for culture and plasmids were 
extracted. To ensure the cloning was correct, the plasmids were subject to sequencing.   
 
2.1.4 DNA sequencing 
The sequencing reactions were carried out with the ABI PRISM® BigDyeTM 
Terminator Cycle Sequencing Ready Reaction Kit (Applied Biosystems). Each 
sequencing reaction (20 µl in total) contained 2 µl of Terminator Ready Reaction Mix 
(BigDye terminators), 4 µl of 5 × sequencing reaction buffer, 3.2 µl of 1 mM 
sequencing primer, 200-500 ng of template DNA. PCR was performed for 27 cycles 
and the conditions were as followed: 96 ˚C for 30 seconds, 50 ˚C for 10 seconds and 
60 ˚C for 30 seconds.  
Once PCR reaction was complete, the DNA products were precipitated with the 
NaOAc/ethanol mixture (2 µl of 3 M NaOAc, pH 4.6 and 50 µl of 95% ethanol). The 
solution was mixed and incubated at room temperature for 15 min followed by 
centrifugation at 13,000 × g for 15 min. The supernatant was discarded and the pellet 
was rinsed with 70% ethanol for two times. Each time, the pellet was incubated for 5 
min and centrifuged for 5 min at room temperature. Finally, the pellet was air-dried 
and dissolved in 10 µl of HiDi. The samples were sent for sequencing in the 
sequencing machine (ABI377 sequencer system).  
 
2.1.5 Rapid amplification of cDNA ends (RACE) 
RACE experiment was aimed to clone the full length zpin1. We used the 
SMARTTM RACE cDNA amplification kit (BD Biosciences). After isolating the adult 
fish total mRNA, 5’-RACE CDS and 3’-RACE CDS primers were adopted to 
synthesize the first-strand cDNA, respectively. Once the 5’-RACE-Ready cDNA and 
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3’-RACE-Ready cDNA were in hand, the specific RACE-PCR was carried out with 
the experiment targeted gene specific primer (GSP) and universal primer mix (UPM) 
provided by the kit. The generated PCR products were sequenced. The eventual full-
length cDNA of zpin1 was assembled from the derived 5'-RACE and 3'-RACE 
sequence.  
The primers used were as follows: 
5’-RACE CDS primer: 5’-(T)25VN-3’ (N=A,C,G, or T; V=A,G, or C) 
3’-RACE CDS primer: 5’-AAGCAGTGGTATCAACGCAGAGTAC(T)30VN-3’ (N= 
A,C,G, or T; V=A,G, or C) 
Universal Primer Mix: 5’-
CTAATACGACTCACTATAGGGCAAGCAGTGGTATCAACGCAGAGT-3’ 
5’-Gene specific primer: 5’-GGCCGCTCCCACTGACTCGCATTGGT-3’ 
3’-Gene specific primer: 5’-GACCCTCGTCCTGGAGAGAGGAGAAC-3’ 
 
2.1.6 Southern Blotting 
2.1.6.1 Probe synthesis  
The probe used in Southern blotting was synthesized with the PCR DIG Probe 
Synthesis Kit (Roche). The final reaction volume was 50 µl with 10 mM forward 
primer 1 µl, 10 mM reverse primer 1 µl, 10 × PCR DIG Labeling Mix 5 µl, 10 × PCR 
buffer 5 µl, enzyme mix 0.75 µl, pGEMT-zPin1 plasmid (template) 0.3 µl and 37 µl 
water. The primer sequences and PCR condition were the same as the above 
mentioned in the 2.1.1 part.  
2.1.6.2 Isolation of genomic DNA 
The adult fish was pulverized in the mortar with the use of pestle. The powder was 
homogenized by adding 10 ml of lysis buffer (10 mM Tris-HCl, pH 8.0; 0.1 M EDTA, 
Materials and Methods 
 43 
pH 8.0; 0.5% SDS; 100 µg/ml of proteinase K) and incubated at 37 °C for 5 h with 
shaking. The mixture was cooled to room temperature and extracted twice with an 
equal volume of phenol: chloroform: isoamyl alcohol mixture (25:24:1). After 
centrifugation at 5,000 × g for 15 min, the aqueous phase was collected and 0.2 
volume of 10 M ammonium acetate together with 2 volumes of pure ethanol were 
added. The solution was mixed thoroughly and the tube was placed at -20 °C for at 
least 20 min. Later, the solution was centrifuged at 3,000 × g for 10 min. The pellet 
was washed with 70% ethanol once and air-dried. The dried pellet was dissolved in 
0.5 ml of Tris buffer (10 mM Tris-HCl, pH 8.0; 1 mM EDTA).  
2.1.6.3 Digestion of genomic DNA 
Genomic DNA was digested with different restriction enzymes: EcoRI, BamHI and 
HindIII. The reaction system contained 10 µl of digested genomic DNA (about 10-15 
mg), 10 µl of 10 × reaction buffer, BSA 10 µl and enzyme 3 µl. The tube was 
incubated in 37 °C water bath for 6 h or overnight. After incubation, the products 
were evaluated by running the DNA gel to check whether the digestion was complete. 
The solution containing 10-15 µg DNA products was concentrated to the final volume 
of 20 µl. The sample was loaded on 1% agarose gel without ethidium bromide (EB) 
and run at 30-40 V for about 2-3 h.  
2.1.6.4 Neutralization, transfer and fixation 
The whole piece of gel was submerged in 250 mM of HCl for 10 min with shaking 
at room temperature. The gel was then washed with deionized water before being 
soaked in the denaturation solution (0.5 M NaOH; 1.5 M NaCl) for 2 × 15 min at 
room temperature. 
The gel was washed with deionized water and was submerged in the neutralization 
solution (0.5 M Tris-HCl pH 7.5; 3 M NaCl) for 2 ×15 min at room temperature. The 
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gel was then rinsed with deionized water. Subsequently, DNA on the gel was 
transferred to the membrane by capillary method using 20 × SSC buffer (0.3 M 
sodium citrate, pH 7.0; 3 M NaCl). The membrane was treated under UV for fixation.  
2.1.6.5 Prehybridization and hybridization  
The membrane was soaked into the DIG Easy Hyb buffer (Roche) with shaking at 
42 °C oven for 2 h. At the same time, the synthesized probe was diluted in 100 µl 
deionized water and boiled in 100 °C water for 10 min. Before use, the probe in water 
was diluted with 15 ml of DIG Easy Hyb buffer. The diluted probe was added onto 
the membrane for incubation at 42 °C overnight.  
2.1.6.6 Washing and blocking  
After incubation, the membrane was washed with 2 × wash solution (2 × SSC, 01% 
SDS) for 2 × 5 min at room temperature. The membrane was then washed with 0.2 × 
wash solution (0.2 × SSC, 01% SDS) for 2 × 15 min at 68 °C followed by wash with 
0.1 × wash solution (0.1 × SSC, 01% SDS) once at 68 °C.  
Subsequently, the membrane was blocked in blocking solution which was the 
Blocking Reagent (Roche) diluted 10 times in maleic acid buffer (0.1 M maleic acid, 
pH 7.5; 0.15 M NaCl) at room temperature for 1 h. 
2.1.6.7 Antibody incubation and detection 
Afterwards, anti-Digoxigen-AP (alkaline phosphatase) (Roche) antibody was 
diluted in blocking solution at the ratio of 1:2000 and the membrane was incubated in 
this AP solution for 30 min at room temperature.  
The solution was discarded and the membrane was washed in washing buffer (0.3% 
Tween 20 in maleic acid buffer) for 2 × 15 min at room temperature. The washing 
buffer was then poured off and the membrane was equilibrated in detection buffer 
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(100 mM Tris-HCl, pH 9.5; 100 mM NaCl). The substrate CDP-star (Roche) was 
diluted 1:100 in the detection buffer and the signal was detected. 
 
2.2 In vitro studies using cell lines 
2.2.1 Cell lines and cell culture 
The cell lines used in the project included: Pin1 wild-type Mouse Embryonic 
Fibroblast (MEF) and Pin1 knock out (Pin1-KO) MEF cells (Fujimori et al., 1999); 
Human Embryonic Kidney (HEK) 293T wild-type (Pin1-WT) and HEK 293T stably 
expressing Pin1 shRNAi cells (Pin1-KD) cells; SH-SY5Y wild-type and SH-SY5Y 
stably expressing Pin1 shRNAi cells (Pin1-KD). The two Pin1-KD cell lines were 
constructed by the technician of our own lab.  
HEK 293T cells and MEF cells were maintained at 37 ˚C in a humidified 
atmosphere containing 5% CO2 in 1 × Dulbecco’s Modified Eagle’s Medium (DMEM, 
Hyclone) supplemented with 10% fetal bovine serum (Hyclone), 2% 750 g/L sodium 
bicarbonate (Gibco), 100 U/ml of penicillin G (Gibco) and 100 µg/ml of streptomycin 
sulfate (Gibco).  
SH-SY5Y cells were grown under similar conditions in a 1:1 mixture of Eagle’s 
Minimum Essential Medium (MEM, Hyclone) with non-essential amino acids and 
Ham’s F12 medium (Hyclone) supplemented with 10% fetal bovine serum (Hyclone).  
 
2.2.2 Transfection and cell lysates collection 
HEK 293T cells were transfected by calcium phosphate method. The confluency 
was about 70-80%. For transfection reagent mixture, expression plasmids were added 
into the deionized water first and 2.5 M CaCl2 was then mixed slowly. The mixture 
was then dropped into 2 × HBS solution (280 mM NaCl; 10 mM KCl; 1.5 mM 
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Na2HPO4; 12 mM glucose; 50 mM Hepes). The mixture was incubated at room 
temperature for 15-30 min before it was resuspended and slowly added into the cell 
culture.  
MEFs and SH-SY5Y cells were transfected with the use of LipofectamineTM 2000 
(Invitrogen) reagent. The required cells confluency was about 90-95% before 
transfection. DNA plasmids and LipofectamineTM 2000 were diluted separately in the 
Opti-MEM I Rduced Serum Medium, and incubated at room temperature for 5 min. 
Later on, the solution was mixed together and incubated at room temperature for 
another 15-30 min. The final step was to add the mixed solution to the cell culture.  
The transfected cells were harvested at about 24 h later. They were first washed 
with PBS (137 mM NaCl; 2.7 mM KCl; 10 mM Na2HPO4; 1.75 mM KH2PO4; pH 7.4) 
for three times and harvested in mammalian cell lysis buffer (50 mM Hepes pH 7.4; 
10% glycerol; 1% Triton X-100; 100 mM NaCl and 0.5 mM MgCl2) supplemented 
with proteinase inhibitors (0.7 µg/ml pepstatin; 0.5 µg/ml leupeptin; 50 µM β-
glycorophosphatase and 1 mM okadaic acid) and phosphatase inhibitor (1 mM 
Na3VO4). The lysates were centrifuged at 4 ˚C for at least half an hour and the 
supernatants were collected for the following Western blotting or pull down assay.  
 
2.2.3 SDS-PAGE and Western blotting 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gels were 
cast with Bio-Rad gel casting system. The gels were composed of resolving gel layer 
and stacking gel layer. Resolving gel concentration ranged from 3-30% which was 
determined by the concentration of acrylamide/bisacrylamide. Take the example of 
12% gel. The resolving gel contained 12% of acrylamide/bisacrylamide mixture (30 
% with a ratio of 29:1) in 0.375 M Tris-HCl pH 8.8 and 0.1% SDS. The stacking gel 
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contained 4 % acrylamide/bisacrylamide in 0.125 M Tris-HCl (pH 6.8) and 0.1 % 
SDS. Polymerization was induced by the addition of 0.1% ammonium persulphate 
(APS) and 0.1% of N, N, N, N-Tetramethyl-Ethylenediamine (TEMED). Protein 
samples were mixed with 2 × SDS sample buffer (100 mM Tris-HCl pH 6.8; 4 % 
SDS; 1% β-mercaptoethanol; 20% glycerol and 0.2% bromophenol blue) and heated 
at 95˚C for 15 min before loading into the gel. Gel electrophoresis was carried out in 
Tris-Glycine buffer (25 mM Tris-base; 192 mM glycine and 0.1% SDS) at a constant 
voltage of 100 V for 2-3 h.   
After SDS-PAGE, the separated proteins were transferred onto Polyvinylidene 
Fluoride (PVDF) membrane (Millipore). The membrane was blocked with 5% skim 
milk powder diluted in1 × TBST (25 mM Tris-HCl pH 7.4; 137 mM NaCl; 0.05% 
Tween-20) for 1 h at room temperature. The membrane was washed in 1 × TBST for 
3 times and then incubated with primary antibodies at 4 ˚C overnight. After three 
times washes in TBST, the membrane was incubated with secondary antibodies 
conjugated with horse radish peroxidase (HRP) for 1 h at room temperature. All 
antibodies were diluted in 1 × TBST buffer. The immunodetection was achieved by 
using Supersignal West Pico Chemiluminescent Substrate Solution (Pierce).  
The primary antibodies we used are listed as follows: 
α-FLAG (Santa Cruz), monoclonal α-HA (Santa Cruz), polyclonal α-HA (Zymed), α-
tubulin (Sigma), α-GFP (Santa Cruz), neuroD (Santa Cruz), monoclonal α-Pin1 (made 
by Dr. Wu Xueji from Xiamen University, China, P. R. C ),  polyclonal α-Pin1 (Shen 
et al., 1998).  
 
2.2.4 Site-directed mutagenesis 
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Site-directed mutagenesis from serine/threonines to alanines on neuroD construct 
(HA-neuroD) was carried out using QuikchangeTM Site-Directed Mutagenesis Kit 
(Stratagene) according to the manufacture’s protocol. The mutagenesis forward 
primers targeting different sites were listed. All the reverse primers were just the 
reverse and complementary to the forward ones.  
Table 2.1: DNA template and primers for site-directed mutagenesis 
Mutant DNA Template Forward Primer 
S157A neuroD WT 5'GAAATCTTGAGGTCGGGCAAAG
CCCCCGACCTGATGTCTTTTG3' 
S259A neuroD WT 5'CCTCACAGACTGCACCGCTCCCT
CATTTGACGGAC3' 
S267A neuroD WT 5'CTCATTTGACGGACCCCTTGCCC
CGCCTTTAAGCGTCAAC3' 
S157A, S259A neuroD S157A 5'CCTCACAGACTGCACCGCTCCCT
CATTTGACGGAC3' 
S157A, S267A neuroD S157A 5'CTCATTTGACGGACCCCTTGCCC
CGCCTTTAAGCGTCAAC3' 




















To investigate the interaction between NeuroD and zPin1 in vivo, Hemagglutinin 
(HA) tagged NeuroD wild-type or NeuroD single, double mutants were transfected 
either with FLAG tagged zPin1 or FLAG vector control. The cell lysates were 
collected in mammalian lysis buffer supplemented with protease inhibitors and 
phosphatase inhibitors. The centrifuged lysates supernatants were incubated with 
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Flag-M2 beads (Sigma) for 1.5 h with shaking at 4 °C. Before incubation, the beads 
were washed with mammalian lysis buffer for two times first. After incubation, the 
beads were then subjected to be washed for 5 times at 8,000 × g. Following that, the 
bound proteins were eluted by 2 × SDS loading dye and analyzed by Western blotting.  
 
2.2.6 Expression and purification of recombinant GST-Pin1 
The expression plasmid pET-42a-GST-zPin1 was transformed into the E. coli 
BL21 (DE3) strain. A single clone carrying the plasmid was picked up and inoculated 
in 100 ml LB broth at 37 °C overnight and transferred to 1 liter TB broth to expand 
the culture. The culture was grown at 37 °C for about 2-3 h until the absorbance value 
of OD600 reached between 0.8-1.2. Expression of the recombinant protein was then 
induced by the addition of isopropyl-beta-D-thiogalactopyranoside (IPTG) to a final 
concentration of 0.8 mM, followed by additional 3 h incubation at 37 °C.  
Following incubation, the bacteria were collected by centrifugation and then 
resuspended in E. coli lysis buffer (50 mM Tris pH 8.0; 0.5 M NaCl; 5% glycerol; 1% 
Triton X-100; 2 mM EDTA) supplemented with protease inhibitors and phosphatase 
inhibitors. Cells were disrupted by ultrasonication of the cells on ice. Cell debris was 
removed by centrifugation at 18,000 × g for 30 min at 4 °C and the supernatant 
lysates were collected.  
 
2.2.7 GST pull-down assay 
The recombinant GST only or GST-zPin1 proteins were immobilized to 
Glutathione Sepharose 4B beads (Amersham Biosciences). The beads were then 
incubated with the cell lysates overexpressing wild-type NeuroD or NeuroD mutants 
at 4 °C rotating for 3 h. The beads were then washed with mammalian cell lysis buffer 
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for 5 times at 4 °C.  After washing, the bound proteins were eluted by boiling in 2 × 
SDS loading dye at 95 °C for 15 min and subsequently analyzed by Western blotting.  
 
2.2.8 Stability and rescue assay 
2.2.8.1 Protein concentration measurement 
The concentration of the collected cell lysates were measured using Protein Assay 
Reagents (Biorad). The standard curve was first plotted with the different 
concentrations of BSA (1 µg/µl – 10 µg/µl). The reaction was carried out by adding 1 
µl of the BSA standard to 799 µl to sterile water. Later, 200 µl of protein assay dye 
was mixed with the diluted BSA standard. After incubation at room temperature for 5 
min, the value of OD595 was read in a spectrophotometer. The graph was plotted with 
protein concentration as the X-axis and the OD595 reading as the Y-axis. After the 
graph was drawn, the protein sample was handled in the same way as the BSA 
standard and also measured at 595 nm. The protein concentration of the samples was 
estimated by comparison against the standard curve.  
2.2.8.2 Stability assay 
For stability assays, HA-NeuroD or its mutants were transfected into HEK 293T 
Pin1-WT and 293T Pin1-KD cells; or MEFs Pin1-WT and Pin1-KO cells, 
respectively. Twenty four hours after transfection, the cells were treated with 
cycloheximide (100 µg/ml; Sigma) to inhibit de novo protein synthesis. The cells were 
then harvested using mammalian cell lysis buffer at the different time points, (i.e 0 h, 
2 h, 4 h and 8 h). The total protein concentrations were determined by protein assay 
using Bio-Rad kit and equal amounts of total proteins for each time point were loaded 
onto SDS-PAGE. The protein levels of NeuroD and its mutants were analyzed by 
Western blotting against anti-HA antibody. 
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2.2.8.3 Rescue assay 
In Pin1-WT and 293T Pin1-KD cells; or MEFs Pin1-WT and Pin1-KO cells, HA-
NeuroD was either co-transfected with FLAG-zPin1 or infection together with 
adenovirus encoding human Pin1. The cells were then treated with cycloheximide and 
harvested at the indicated time points as mentioned previously. After adjusting protein 
concentration, the same amounts of cell lysates were loaded onto the SDS-PAGE and 
analyzed by Western blotting with anti-HA, anti-FLAG and tubulin antibodies.  
 
2.2.9 Immunostaining  
SH-SY5Y cells were plated on coverslips in 12-well plates before transfection. The 
cells were co-transfected with GFP-zPin1 and HA-NeuroD plasmids. After 24 h, cells 
were washed with 1 × PBS and fixed with 4% paraformaldehyde (PFA) for 30 min at 
room temperature. After that, the cells were washed with PBS and blocked with 3% 
BSA and 0.1% Triton X-100 in PBS for 30 min at room temperature. After washing, 
the cells were incubated with the mouse monoclonal anti-HA antibody and the rabbit 
polyclonal anti-GFP antibody diluted in the blocking reagent buffer for 1 h at room 
temperature. Subsequently, the cells were incubated with Alexa Fluor-conjugated 
secondary antibodies (Molecular Probes) for 1 h at room temperature. After washing, 
cell nucleus 4'-6-Diamidino-2-phenylindole (DAPI) staining was then performed for 
10 min at room temperature. Finally, the coverslips were mounted with FluorSave 
(Calbiochem) and examined by confocal fluorescence microscope (Zeiss META 
LSM510).  
 
2.3 In vivo studies using zebrafish embryos 
2.3.1 Maintenance and staging of zebrafish strains 
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All the fish strains used in this work were provided by Institute of Molecular and 
Cell Biology, Singapore (IMCB). The lines included normal wild-type (AB line), ET4 
transgenic fish line (Parinov et al., 2004), and ET33-mi20 line which was generated 
by inserting Transposon Tol2 into the first exon of ngn1. The fish were maintained in 
a closed circulatory system (Aquatic Habitat, USA) in UV sterilized egg water (Sea 
salts 60 µg/ml in distilled water) at 28 °C. The embryos were staged based on the 
criteria described by Kimmel (Kimmel et al., 1995). 
 
2.3.2 In vitro transcription 
The coding region of zpin1 was ligated into pCS2+ vector. zpin1 mRNA was 
synthesized with the MEGAscript® SP6 Kit (Ambion). The pCS2+ carrying zpin1 
gene was first linearized with the specific restriction enzyme and the product was 
purified. This procedure was the same with that described in 2.1.3. After purification, 
transcription reaction solution mixture was assembled with 1 µg of linearized plasmid, 
2 µl of reaction buffer, 10 µl of 2 × NTP/CAP (ribonucleotides) and 2 µl of enzyme 
mix. The mixture was incubated at 37 ºC for 2 h and purified with lithium chloride 
(LiCl). The precipitation was carried out by adding 30 µl of water plus 30 µl of LiCl 
solution. The solution was mixed thoroughly and chilled at -20 ºC for 30 min. The 
mixture was then centrifuged at 4 ºC for 15 min at 13,000 × g to pellet RNA. The 
supernatant was removed and the pellet was washed with 70% ethanol once. After 
spinning, the ethanol was removed and the pellet was air-dried. The pellet was 
dissolved in the nuclease-free water or TE buffer for future use.  
 
2.3.3 Microinjection 
Materials and Methods 
 53 
Morpholino (MO) antisense oligonucleotides (Gene-tools) were injected at 
different concentrations ranging from 0.5 to 1 pmol in 1 × Danieau buffer (58 mM 
NaCl; 0.7 mM KCl; 0.4 mM MgSO4; 0.6 mM Ca(NO3)2; 5.0 mM hepes pH 7.6). 
RNAs to be injected were diluted in water at various concentrations. The needles used 
for  microinjection were prepared using optimized conditions of heat and pull time for 
different purposes using the Sutter Micropipette puller P-97 (Sutter Instruments Co, 
USA). The conditions for normal injections into 1-2 cell stage were Pressure-500, 
heat-500/550, pull-150/150, velocity-100/100 and time-150/150.  
The injection was performed when the embryo was at 1-2 cell stage and the 
injection was done using Picoinjector PLI-100 (Medical Systems Corp, Greenvale, 
NY, USA) by placing the embryos under a dissection microscope (Olympus SZX12). 
Each embryo received a specific volume of the samples depending on the 
concentration of the sample. The sequences of MOs were as follows: 
zpin1 MO1 (targets translation initiation site of zpin1):  
5’- ACGGCAGCTTCTCGTCATCGGACAT-3’  
zpin1 MO2 (targets 5’-UTR of zpin1):  
5’-GATTGCAGGACGGCTCGGTTCGG-3’ 
Standard control MO: 5’-CCTCTTACCTCAGTTACAATTTATA-3’ 
neuroD MO: 5’-TGACTTCGTCATGTCGGAACTCTAG-3’ 
 
2.3.4 In situ hybridization  
2.3.4.1 Synthesis of labeled RNA probe 
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To synthesize RNA probe, plasmid DNAs were linearized at the 5’ end of the 
cDNA insert with the right restriction enzymes at 37 °C for 2 h. The linearized 
plasmid was purified by phenol: chloroform precipitation. The addition of phenol: 
chloroform was followed by centrifugation at 14,000 × g for 5 min at room 
temperature. The top layer was removed to a fresh tube and DNA was pelleted by 
ethanol. The mix was incubated on ice for 30-45 min and centrifuged for another 30-
45 min. The supernatant was carefully discarded and the pellet was washed with 75% 
ethanol and spun for 5 minutes at 14,000 rpm. The pellet was then resuspended in 50-
100 µl of sterile water or TE buffer for further use. 
1 µg of linearized DNA was used to synthesize the digoxigenin (DIG)-labelled 
probe. The reaction was performed at 37 °C for 2 h in a total volume of 20 µl, 
containing 2 µl of 10 × transcription buffer (Roche), 2 µl of DIG RNA labeling mix 
(Roche),1 µl of RNase inhibitor (40 U/µl) (Roche) and 1 µl of proper RNA 
polymerase (Roche). Following that, RNase-free DNase was used to digest the DNA 
template at 37 °C for half an hour and EDTA (pH 8.0) was used to stop the restriction 
digestion. Subsequently, LiCl/ethanol was used to precipitate the RNA. After washing 
with 75% ethanol, the RNA probe was resuspended in DEPC treated water. The 
labeled probe was quantified visually by running agarose gel and quantitated using 
spectrophotometric analysis at OD260/280 nm. 
Probes used in this project with Genebank Accession Number in the bracket: 
zpin1 (NM200748), neuroD (NM 130978), neurogenin1 (NM 131041), neuroM (NM 
170762), pax 6 (NM 131304), otx2b (NM 131251), islet-1 (NM 130962) , nkx2.2 
(NM 131422), insulin (NM 131825), her4 (NM 131090). 
2.3.4.2 Embryos collection and fixation 
Materials and Methods 
 55 
Embryos at 18 hpf, 24 hpf or 48 hpf were fixed in 4% PFA for 12 to 24 h at room 
temperature or 4 °C. Embryos younger than 16 hpf were fixed before echorionization 
and the chorion was removed afterwards. Embryos older than 16 hpf were 
dechorionated before fixation. Older embryos with tails were hibernated on ice before 
fixation to prevent the curling of tails. After fixation, the embryos were washed in 
PBST (0.1% Tween20 in PBS) for 4 × 15-20 min at room temperature.  
2.3.4.3 Proteinase K treatment  
This step was especially necessary for embryos older than 14 somites (>16 hpf). 
Embryos were treated with 10 µg/ml of proteinase K in 1 × PBST at room 
temperature. The time of exposure depended upon embryos age and the specific 
activity of proteinase K, which varied from batch to batch. For most cases, the 
conditions used were as below. 
16-24 hpf embryos, 3-4 min 
24-32 hpf embryos, 5-6 min 
32-50 hpf embryos, 10-20 min 
To stop the reaction, the proteinase K solution was removed completely, and the 
embryos were re-fixed in 4% PFA for 20 min at room temperature. The embryos were 
then washed in PBST for 4 × 15-20 min at room temperature.  
2.3.4.4 Prehybridization 
Prehybridization was performed by adding hybridization buffer [50% formamide; 5 
× SSC; 50 µg/ml heparin; 500 µg/ml tRNA; Tween 20 0.1%; pH 6.0 (adjusted by 
citric acid)]. The embryos were incubated at 68 °C for 5-10 h. 
2.3.4.5 Hybridization 
The synthesized DIG-labeled probes were diluted in hybridization buffer to the 
final concentration of 1 ng/µl. The probes were denatured by heating at 80 °C for 5 
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min followed by 5 min on ice bath. The denatured probes dissolved in hybridization 
buffer were then added into the prehybridized embryos. The tubes were placed into 
the water bath at 68 °C for overnight.  
2.3.4.6 Post-hybridization washes 
The probe was removed and replaced with prewarmed 100% hybridization wash 
solution (hybridization buffer without tRNA and heparine) for 15 min. The embryos 
were then washed in the gradient of wash solutions, 15-20 min each: 75% 
hybridization wash solution plus 25% 2 × SSCT (SSC with 0.1% Tween 20); 50% 
hybridization wash solution plus 50% 2 × SSCT; 25% hybridization wash solution 
plus 75% 2 × SSCT. This was followed by 2 × SSCT wash for 2 × 30 min and 0.2 × 
SSCT wash for another 2 × 30 min. Subsequently, the embryos were washed twice 
with PBST at room temperature for 5 min each. 
2.3.4.7 Antibody incubation 
Commercial DIG-AP antibody (Roche) was preincubated with biological tissues, 
preferably of the same origin as the sample used for hybridization, in order to 
decrease the staining background and increase signal-to-noise ratio. Thus, DIG-AP 
was diluted to 1:500 in the blocking mixture solution which was the blocking reagent 
(Roche) dissolved in maleic acid buffer (0.15 M maleic acid; 0.1 M NaCl, pH 7.5) to 
1%, and incubated with 50 zebrafish embryos of any stages at 4 °C for overnight.  
The antibody solution was transferred to a new tube and diluted to 1:5000 with the 
blocking mixture solution. The preabsorbed antibody was stored at 4 °C and can be 
used for many times. 
The embryos after hybridization and post hybridization washes were incubated in 
the blocking mixture solution for 2 h at room temperature for blocking. After 
Materials and Methods 
 57 
removing the blocking solution, the embryos were incubated with preabsorbed anti-
DIG-AP antibody at 4 °C overnight.  
2.3.4.8 Color development 
Embryos were washed in 1 × PBST for 4 × 15-20 min on a nutator at room 
temperature followed by washing in buffer 9.5 (0.1 M Tris-HCl, pH 9.5; 50 mM 
MgCl2; 10 mM NaCl and 0.1% Tween 20) once for 30 seconds and twice for 10 min 
each. Following that, 4.5 µl of NBT (Nitroblue tetrazolium, Boehringer Mannheim, 
50 mg/ml in 70% dimethyl formamide) and 3.5 µl of BCIP (5-bromo, 4-chloro, 3-
indodyl phosphate salt, 50 mg/ml in H2O; Roche) was added into 1 ml of buffer 9.5 
(pH 9.5) with embryos and mixed thoroughly. Embryos were kept in dark at room 
temperature for few minutes to several hours, and the staining was checked from time 
to time under a Leica MZ12 microscope (Leica) until the staining was properly 
developed. The reaction was stopped by removing the staining solution and washing 
with PBST. The stained embryos can be saved in the 50% PBS plus 50% glycerol 
solution.   
2.3.4.9 Mounting and photographing 
After staining the embryos, for the whole mounts, a chamber was made by placing 
stacks of 2-5 pieces of small cover slips on both sides of a microscope slide. The nail 
polish was used to attach them together and to the surface of the slides.  
The staining embryos were transferred to the chamber in its stocking solution 50% 
glycerol/PBS and oriented by a needle. A 22 × 44 mm cover slip with a small drop of 
the same buffer was superimposed onto the embryo. By gently moving the cover slip, 
the orientation of the embryo can be adjusted to the right position.  
For the flat mounting, the yolk of the embryo was removed totally first. The left 
embryo body was placed onto a slide and the excess solution was sucked out in the 
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process of orientating the embryo. A small piece of cover slip was place onto the 
sample with great care to avoid the bubbles. A drop of 50% glycerol/PBS was added 
to fill the space beneath the cover slip. This specimen was sealed by spreading the nail 
polish along the edge of the cover slip. Photographs were taking under the Olympus 
AX-70 microscope (Olympus).  
 
2.3.5 Immunohistochemical staining on embryos  
Embryos were staged and fixed as described. After washing in 1 × PBST for 4 
times, the embryos were treated with cold acetone for 15 min to improve the 
penetration of antibodies. The embryos were then washed in PBST and subjected to 
blocking mixture solution as used in the in situ hybridization experiment.  
The embryos were then incubated with primary antibody 1:500 diluted in the 
blocking mix solution at 4 ºC for overnight. The primary antibodies included anti-
GFP (Santa Cruz) and anti-acetylated tubulin (Sigma).  
After removing the primary antibody, embryos were washed in 1 × PBST for 4 × 
15-20 min on a nutator at room temperature. The embryos were then incubated with 
Alexa Fluor 488 or 594 F(ab')2 secondary antibodies (1:500) at 4 ºC for overnight. 
The embryos were washed in 1 × PBST for 4 × 15-20 min with shaking at room 
temperature and observed under the fluorescence microscope (Zeiss META LSM510). 
 
2.3.6 Acridine Orange staining 
   Live embryos were dechorionated at 24 hpf and placed in 50 µg/ml of acridine 
orange (acridinium chloride hemi-[zinc chloride], Sigma) solution diluted in egg 
water. The embryos were stained for 10 min, and then washed for 6 times of 5 min 
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with egg water. Lastly, embryos were anethetized with 0.016 M tricaine and mounted 
in agarose for imaging.  
 
2.3.7 Total RNA extraction from zebrafish embryos 
The embryos were collected at 1 cell stage, 4 hpf, 10 hpf, 13 hpf, 24 hpf, 36 hpf, 48 
hpf, 60 hpf and 72 hpf, respectively. The embryos before 48 hpf were dechorionated 
before collection. Total RNA extraction was performed with the reagent TRIzol 
(Invitrogen). The embryos were homogenized by pestling with the pestle in TRIzol 
reagent until the solution became homogeneous.  
The resultant lysate was incubated at room temperature for 5 min and chloroform 
was added into the sample. The tube was shaken vigorously and incubated for 2-3 min 
at room temperature. The clear aqueous phase was completely separated from the red 
organic phase by spinning at 12,000 × g for 15 min at 4 °C. After centrifugation, the 
clear aqueous layer was transferred to a new tube. Isopropyl alcohol was added to 
precipitate RNA. The tube was incubated for 10 min at room temperature and 
centrifuged at 12,000 × g for 10 min at 4 °C. The supernatants were removed. The 
pellet was washed with 75% ethanol for one time. The sample was mixed by 
vortexing and centrifuged at no more than 7,500 × g for 5 min at 4 °C. Finally, the 
pellet was dry and dissolved in 30-40 µl of DEPC-treated water and incubated for 10 
min at 55 °C to 60 °C.  
 
2.3.8 Reverse-transcriptase PCR (RT-PCR) 
 After isolation of total mRNA, cDNA was synthesized using the SuperScript 
reverse transcriptase (Invitrogen). The cDNAs from various stages were used as the 
templates to amplify the zPin1 transcript with actin as the internal loading control. 
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PCR products were analyzed on a 1% agarose gel containing ethidium bromide (EB). 
The primers utilized in this project were listed below:   
actin sense: 5’-GCACGAGAGATCTTCACTCCCCTTG-3’ 
actin antisense: 5’-CATCACCAGAGTCCATCACAATACC-3’ 
zpin1 sense: 5’-ATGTCCGATGACGACGAGAAGCT-3’ 
zpin1 antisense: 5’-GCGTGTGATGTTCTCCTCTC-3’ 
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Chapter 3 Results 
3.1 Molecular analysis of zebrafish Pin1 
3.1.1 Characterization of zebrafish Pin1  
To examine the function of ZPin1 during zebrafish development, we cloned 
zebrafish full-length Pin1. To achieve this aim, Rapid Amplification of cDNA Ends 
(RACE) experiment was carried out. Finally, 5’-RACE and 3’-RACE fragments were 
assembled to get full-length zPin1. As shown in Fig. 3.1, full–length Pin1 contains 81 
bp of 5’- untranslated region (UTR), 480 bp of open reading frame (ORF) and 342 bp 
of 3’-UTR.  
To characterize zebrafish Pin1 genomic structure, we used 477 bp of zebrafish Pin1 
coding region to perform an online BLAST search of zebrafish genome database. 
However, only one small fragment (about 110 bp) without introns was retrieved, in 
contrast, three introns were found both in human and mouse Pin1. Therefore, we can 
only design morpholinos against 5’-UTR and translation initiation sites to knock 










Figure 3.1 Full-length cDNA sequence of zebrafish Pin1. RACE experiment 
was performed from both 5’ and 3’ ends. The sequences were assembled to 
obtain zebrafish Pin1 full length sequence. The base pairs in red represent the 5’-










3.1.2 Sequence alignment of Pin1 in various species 
From RACE result, we identified that zPin1 contained an ORF of 480 bp, encoding 
a protein of 159 amino acid residues. Multiple sequence alignment of Pin1 from 
diverse species (Fig. 3.2A) indicated that Pin1 isomerase was highly conserved 
among human, mouse, zebrafish and Xenopus. In detail, zebrafish Pin1 shared 79%, 
79% and 78% identity to that of human, mouse and Xenopus Pin1, respectively. The 
high identity implied that Pin1 function can also be conserved and Pin1 might 
substitute each other functionally in different species. Furthermore, phylogenetic 
analysis of Pin1 (Fig. 3.2B) demonstrated that zebrafish Pin1 was most closely related 
to Xenopus Pin1. Given the similarity between Xenopus and Zebrafish model, we can 
take preceding Pin1 study in Xenopus as the reference for our following study in 























Figure 3.2 Amino acid sequence alignment of Pin1 in different species. (A) Amino acid 
sequence alignment of Pin1 in Drosophila (dodo), budding yeast (Ess1), Xenopus (xPin1), 
zebrafish (zPin1), mouse (mPin1) and human (hPin1). Identical sequences in all species are 
shown in red. The residues that are identical only in some organisms are indicated by blue 
color. The numbers refer to amino acid positions of zebrafish Pin1. (B) Phylogenetic tree 
comparing Pin1 homologs in 6 different species. The tree is conducted using ClustalW 







3.1.3 Expression pattern of zPin1 in zebrafish embryos  
To determine the temporal expression pattern of zPin1 during development, 
zebrafish embryos were examined by RT-PCR. Our data revealed that zPin1 
expresses early at one cell stage (Fig. 3.3A). From the onset of midblastula transition 
(MBT) at about 3 hpf through 72 hpf stage, the level of zPin1 transcripts remained 
constant, suggesting that zPin1 plays an important role during early developmental 
process of zebrafish.   
To further examine the role of zPin1 on specific tissues during zebrafish 
development, we performed Western blot analysis to investigate zPin1 spatial 
expression pattern in various fish tissues. It turned out that zebrafish Pin1 expression 
was ubiquitous, with more intense expression being detected in the brain and testis 
(Fig. 3.3B). This result coincided with a previous study in mice, indicating an 
essential role of Pin1 on these two tissues (Liou et al., 2002).  
To verify the spatial-temporal expression pattern of zpin1 in vivo, we performed 
whole-mount in situ hybridization using Dig-labeled zpin1 antisense RNA as the 
probe. At 14 hpf, expression of zpin1 was widespread throughout the whole embryo 
(Fig. 3.4A and B). When embryos developed at 24 hpf through 48 hpf, zpin1 
expression signal was restricted to the brain region as shown in Fig. 3.4C, D and E. 
Hence, we focused to examine expression of zpin1 specifically on the brain in Figure. 
3.4E, we demonstrated that zpin1 expression was still in a ubiquitous manner and 
evenly distributed in forebrain, midbrain and hindbrain region.  
   To obtain a distinguished expression pattern of zpin1 transcripts, we performed in 
situ hybridization with the modified protocol by lowering hybridization temperature 
from 68 ˚C to 58 ˚C and extending staining time to 3-4 hours. Under such conditions, 
zPin1 transcripts can be detected on the lateral line neuromasts (Fig. 3.4F, arrows). 
Results 
 66 
Signal seemed to be distributed in the entire neuromast, inclusive of hair cells and 
mantle cells. For all the in situ assays, mock staining was performed with zPin1 sense 
RNA as probe. As expected, no staining was detected on any region of embryos. 
Previous studies strongly indicated that Pin1 was essential for neuron 
differentiation and loss of Pin1 can cause motor and behavioural defects in Pin1 
knock out mice (Liou et al., 2003). Considering this role of Pin1 in neuron 
differentiation and zPin1 expression pattern in vivo, we speculate a prominent role of 
zPin1 for neuron development, especially for formation of neuromasts in zebrafish. 



































































Figure 3.3 zPin1 spatial and temporal expression patterns. (A) Reverse transcription 
analysis of zpin1 mRNA expression in zebrafish embryonic development. The upper panel 
shows zpin1 mRNA level at different stages and the lower panel shows the results for β-
actin as the control. (B) zPin1 protein expression levels in adult zebrafish tissues. Western 
blotting was applied using adult zebrafish lysates from different tissues (polyclonal α-Pin1 
antibody was used). The upper panel shows zPin1 protein expression in different indicated 
tissues. The lower panel is loading control, stained by Coomassie Blue and each lane 






















































































































Figure  3.4 In situ hybridization analysis of  zpin1 expression at different stages. (A) 
14 hpf stage embryo at 60 × magnification. (B) 14 hpf stage embryo at 100 × magnification. 
(C) 24 hpf stage embryo at 40 × magnification. (D) 24 hpf stage embryo at 100 × 
magnification. (E) 48 hpf stage embryo at 100 × magnification. (F) 48 hpf stage embryo 
focusing on the lateral line neuromasts. MHB: midbrain-hindbrain boundary. Arrows in F 
indicates the neuromasts staining.  
MHB
48 h F 48 h
A 14 h 14 hB




3.2 Relationship between zPin1 and NeuroD 
3.2.1 The binding of zPin1 with NeuroD and Ath1 
Pin1 can isomerize conformational changes of phosphorylated cis/trans peptidyl-
prolyl bonds and regulate biological function of its targets. A great number of human 
Pin1 binding partners have been identified since its discovery in 1996 (Lu et al., 
2007). Consequently, discoveries on human Pin1 provide a novel and key mechanism 
for post-translational modification in various species. 
NeuroD, a helix-loop-helix transcription factor, contains five Ser/Thr-Pro motifs 
and three of which have been reported to be phosphorylated by ERK2 or GSK3β, 
which mimicks potential Pin1 binding motifs (Dufton et al., 2005). Therefore, it is 
likely that Pin1 can interact with NeuroD. To test this hypothesis, we performed 
colocalization and pulldown experiments.   
SH-SY5Y cells, a kind of neuroblastoma cells, were chosen for this colocalization 
experiment because NeuroD was a proneural gene essential for neuron differentiation 
(Lee et al., 1995). We transfected GFP-zPin1 and HA-neuroD into cells and stained 
them with primary anti-GFP and anti-HA antibodies followed by secondary 
antibodies conjugated with fluorophores 488 and 568, respectively. The stained cells 
in Fig. 3.5A revealed that NeuroD was predominantly localized in nucleus. For zPin1, 
mostly it resided in nucleus, with some signal being detected in cytoplasm, depending 
on availability of its phosphorylated substrates (Lu et al., 2002). The merged picture 
in Fig. 3.5A clearly exhibited co-localization of NeuroD and zPin1 in nucleus.  
Subsequently, an in vivo co-immunoprecipitation (Co-IP) FLAG pulldown 
experiment was performed. We co-transfected HEK 293T cells with FLAG-zPin1 and 
HA-NeuroD and then carried out FLAG pulldown assay using harvested whole cell 
lysates. Anti-FLAG and anti-HA antibodies were used to detect zPin1 and NeuroD, 
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respectively. As shown in Fig. 3.5B (arrow), our results revealed that FLAG-zPin1 
was able to pull down HA-NeuroD, suggesting that zPin1 and NeuroD can interact 
with each other in vivo. The binding of zPin1 and NeuroD indicated that zPin1 may 
regulate NeuroD post-translationally and laid foundation for all our subsequent 
studies.  
Besides, we revealed the interaction between zPin1 and Ath1 by conducting GST-
pulldown assay (Fig. 3.5C). Ath1 is zebrafish atonal homolog 1 which was reported to 
act upstream of NeuroD for development of hair cells (Sarrazin et al., 2006). 
Considering involvement of both NeuroD and Ath1 in the formation of neuromasts, 
we hypothesized that zPin1 may be implicated in neuromasts hair cells development. 
To confirm the role of zPin1 in neuromasts formation, we still need phenotypic 


































































































































































              
Figure 3.5 zPin1 interacts with NeuroD and Ath1. (A) NeuroD co-localizes with zPin1 in 
cell nucleus. GFP-zPin1 and HA-neuroD were transfected into SH-SY5Y cells. After 24 h, 
cells were fixed and stained with rabbit anti-GFP antibody as well as mouse anti-HA antibody 
followed by anti-rabbit fluorophore 488 and anti-mouse fluorophore 568. Finally cells were 
stained with DAPI for recognition of nucleus. (B) zPin1 interacts with NeuroD in vivo. HEK 
293T cells were co-transfected with FLAG-zPin1 and HA-NeuroD. Collected cell lysates 
were immunoprecipitated with FLAG beads for 1.5 h at 4 °C and analyzed by Western 
blotting with anti-FLAG and anti-HA antibodies. An empty FLAG vector together with HA-
neuroD transfection was used as negative control. The arrow points to pulldown band. (C) 
zPin1 interacts with Ath1. HEK 293T cells were transfected with HA-neuroD or HA-ath1. 
After 24 h, lysates were collected and subjected to GST or GST-zPin1 beads for pulldown. 
Beads were washed and analyzed for Western blotting. The binding of zPin1 with NeuroD 





























3.2.2 The interaction of zPin1 with NeuroD via pSer/Thr-Pro motif 
As an isomerase, Pin1 was reported to catalyze cis-trans isomerization of only 
phosphorylated Ser/Thr-Pro bonds. After demonstrating interaction of zPin1 with 
neuroD in Fig. 3.5B, we further investigated whether this interaction was dependent 
on the phosphorylation of NeuroD. 
To confirm the importance of NeuroD phosphorylation, whole-cell lysates from 
cells transfected with HA-NeuroD were treated with calf intestine alkaline 
phosphatase (CIAP) and analyzed for their ability to bind with GST-zPin1 in GST 
pull down experiment. As expected, phosphatase treated lysates resulted in 55% 
decrease of the interaction between NeuroD and zPin1, compared with that of non-
treated normal cell lysates (Fig. 3.6A), suggesting that the interaction was indeed 
phosphorylation dependent.  
Previous NeuroD paper published in 2004 by Dufton et al. revealed that in Xenopus, 
Ser259, Ser266 and Ser274 were phosphorylation targets of ERK2. S274 can also be 
phosphorylated by GSK3β (Dufton et al., 2005). Both of the proline-directed kinases 
are well-known to provide phosphorylated substrates for Pin1 isomerization. 
Therefore, we mutated the corresponding three Serine sites to Alanines on zebrafish 
NeuroD individually and performed either co-immunoprecipitation assay or GST 
pulldown assay. Our data in Fig. 3.6B demonstrated that when mutated alone, none of 
the single mutation (S157A, S259A and S267A) appeared to affect binding with 
zPin1 significantly.  
It was reported that Pin1 might act on multiple pSer/Thr-Pro motifs for its binding 
and isomerization activity. Three combinations of double mutants (D1: S157AS259A; 
D2: S157AS267A; D3: S259AS267A) were made and were examined for their 
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binding ability with zPin1. However, all three double mutants did not influence 
interaction compared with wild type one, as displayed in Fig. 3.6C.  
Following that, NeuroD 3A mutant (S157AS259AS267A) was constructed. In 
addition, another Ser to Ala mutation was also added (S223A) and we called it 
NeuroD 4A mutant (S157AS223AS259AS267A). GST-pulldown experiment was 
carried out to investigate the binding ability and it was found that both of 3A and 4A 
NeuroD showed slight reduction for the binding with zPin1 (Fig. 3.6D). This result 
highly suggested that the interaction of NeuroD with zPin1 relied on the cooperation 
of several of Ser/Thr sites on NeuroD.  
Finally, all five potential zPin1 binding sites on NeuroD were mutated to 
Alanines.This mutant was NeuroD 5A mutant (T218AS223AS157AS259AS267A). 
Our GST-pulldown assay revealed that mutation of all five potential binding motifs of 
NeuroD led to a significant decrease (60%) in the ability of NeuroD to bind to zPin1. 
This reduction of binding was much more pronounced than NeuroD 3A and 4A 
binding with zPin1. This result highly suggested that the interaction of NeuroD with 
zPin1 relied on the cooperation of several of Ser/Thr sites on NeuroD and all five 
































































































































































































Figure 3.6 Identification of zPin1 potential Ser/Thr-Pro binding motifs on 
NeuroD. (A) The binding between NeuroD and zPin1 was phosphorylation dependent. 
293T cell lysates transfected with HA-NeuroD were treated with phosphatase for one 
hour in 37 °C waterbath. The lysates were then subject to GST-pulldown for 3 h at 4 
°C. After washing, the beads were analyzed with Western blotting method. HA 
antibody was used to detect the presence of pulldown NeuroD. (B) Single mutation of 
Serine to alanine in NeuroD did not affect binding of NeuroD with Pin1. 293T cells 
were co-transfected with HA-NeuroD and Flag-zPin1 and cell lysated were collected 
for FLAG beads pull down. After 2 h incubation with FLAG beads at 4 °C, the beads 
were washed and analyzed by Western blotting. Anti-HA and anti-FLAG antibodies 
were used to detect NeuroD and Pin1, respectively. (C) Double mutations of serine to 
alanines on NeuroD had no effect on its binding ability to Pin1. This process was 
conducted similarly with B. (D) NeuroD 3A and 4A mutatants displayed a slight 
reduction of binding with zPin1. NeuroD 3A and 4A constructs were transfected into 
293T cells followed by GST- pull down as in A. (E) NeuroD 5A mutant showed great 
reduction for its binding affinity to zPin1. GST-pulldown assay was performed as in A 








3.3 zPin1 morpholino knockdown phenotypes 
3.3.1 The knockdown efficiency of both zPin1 morpholinos 
Morpholino oligonucleotides (MOs)-mediated knockdown of genes in zebrafish 
embryos has become a routine and efficient method to provide information about gene 
function in vivo. To elucidate function of zPin1 during zebrafish development, we 
designed two specific Pin1 morpholinos against the translation initiation region of 
zPin1-coding sequence (MO1) and 5’-UTR region (MO2), respectively. The diagram 
is depicted in Fig. 3.7A. Due to the incomplete sequencing of zebrafish genome, we 
failed to find any introns for zPin1. As a result, we were not able to design 
morpholinos against intron-exon boundaries.  
To test efficiency and specificity of the two morpholinos, we injected morpholinos 
into zebrafish embryos and conducted Western blotting to examine whether 
endogenous zPin1 protein level was indeed reduced. As a negative control, 
morpholino standard control was injected into embryos in a gradient concentration at 
the same time. Western blotting result revealed that the protein level of zPin1 
remained same for standard morpholino injected embryos, while, the zPin1 level was 
reduced in MO1 injected embryos. Moreover, the degree of zPin1 level reduction 
correlated with MO1 concentration increase (Fig. 3.7B). The reduction precentage of 
zPin1 protein level ranges from 30% (0.3 pmol) to 50% (0.6 pmol) and 60% (0.8 
pmol). The result was same for zPin1 MO2, indicative of the specificity of zPin1 
morpholinos. Therefore, Western blotting assays confirmed the knockdown efficiency 




























































































































Figure 3.7 The reduction of zPin1 expression in zPin1 morphant embryos. (A) The 
diagram of zPin1 sequence and design scheme of two zPin1 morpholinos. (B) Embryos 
were injected with either standard control morpholino or zPin1 MO1 at the concentration of 
0.4 pmol, 0.6 pmol and 0.8 pmol respectively. At 24 hpf, wild type, control embryos and 
zPin1 MO1-injected embryos were collected and protein was extracted. Western blotting 
was performed to determine zPin1 protein level with β-tubulin as loading control. Embryos 
were injected with MO2 at concentration of 0.6 pmol and Western blotting was used to 











3.3.2 Developmental delay caused by zPin1 loss-of-function 
To investigate function of zPin1 in zebrafish development, we injected zPin1 
morpholino into embryos and characterized general defects of those morpholino-
injected embryos.  
The general phenotype is shown in Fig. 3.8. Before we analyzed this result 
carefully, we first introduce the staging index of zebrafish embryos. Before 24 hpf, 
the stage of embryos can be judged by the number of somites. After 24 hpf, embryos 
stage can be judged from head-trunk angle (Kimmel et al., 1995). The angle ranges 
from 120 o at 24 hpf to about 45 o when embryos develop to 48 hpf stage. 
Followingour own result, the figure revealed that at 18 hpf, wild type embryos 
contained 18 somites while morpholino-injected embryos only possessed 
approximately about 16 somites, which indicated that morpholino-injected embryos 
had one hour developmental delay. When wild type embryos developed to 24 hpf, 
morpholino-injected embryos reached about 22 hpf stage. Afterwards, when wild type 
embryos arrived at 48 hpf, morpholino-injected embryos only reached to 41-42 hour. 
It means that morpholino-injected embryos developed 6 hours slower than wild type 
control embryos at the time of 2 day (Fig. 3.8).  
Furthermore, statistical data in Table 3.1 clearly showed that all zPin1 MO injected 
embryos displayed developmental delay and this delay was in a dose-dependent 
manner. When the injected morpholino amount was increased from about 0.3 pmol to 
0.6 and even 0.8 pmol, phenotypes of developmental delay became more and more 
evident as shown by delay hour. When the injected morpholino amount arrived at 0.8 
pmol, all embryos displayed toxic effects of morpholinos with global apoptosis, 
malformed brain as well as edema. Thus, we can not use amount exceeding 0.6 pmol. 
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In subsequent studies, zPin1 MO1 was injected at the amount of around 0.5 pmol to 
0.6 pmol.  
The delayed development could be partly attributed to cell cycle defects as 
demonstrated by previous studies. It was reported that Pin1 can impair the 
proliferation of PGC by prolonging cell cycle. As a result, fewer cell divisions 
occurred and the number of PGCs was reduced, leading to the total loss of germ cells 
by 14 month for Pin1 knock-out mice (Atchison et al., 2004). The study on PGCs 
indicated an essential role of Pin1 in cell cycle progression. Hence, when zPin1 
protein level was knocked down by morpholino injection in zebrafish embryos, it was 
highly possible that the length of cell cycle could also be prolonged. Consequently, 
the developmental process of embryos would be slowed down progressively and 
finally delayed, as revealed in Fig. 3.8.  
To conclude, Fig. 3.8 depicts developmental delay phenotypes after zPin1 level was 
knocked down compared with wild type non-injected embryos. Meanwhile, we 
injected standard morpholino into embryos and found no obvious delay (data not 
shown). Therefore, in our subsequent studies, we did not inject standard morpholino 
and only used wild type ones as the control.  
In all our subsequent assays, we chose to use 48 hpf embryos for several resons. 
Firstly, it is possible for us to stage embryos at this point so as to allow the collection 
at the same time. Secondly, we are sure that morpholinos work at 48 hpf.  Thirdly, 



















Figure 3.8 Developmental delay in zPin1 morphant embryos. zPin1 MO1 was injected 
into embryos and general phenotype was observed. At 18 h (A, A’), 24 h (B, B’), 32 h (C, C’) 
and 48 h (D, D’), non-injected wild type embryos and injected embryos were photographed 
and compared.  
 
Table 3.1: zPin1 MO led to delay in development 
   
Dose injected Number (n) Delayed at 24 h Delayed at 48 h 
0.3 pmol 72 1 3-4 
0.6 pmol 53 2 5-6 
0.8 pmol 61 4 >6 
*All the injected embryos showed delay phenotype  






















The time differences between wild type and zPin1 knockdown embryos made it 
impossible for us to collect those embryos at the same time for experiments. 
Therefore, to exclude this effect of developmental delay, we collected wild type 
embryos first and morpholino-injected embryos 2 hours later at 24 hpf or 6 hours later 
at 48 hpf when they developed to the same stage as wild type embryos. In the 
following experiments and figures, we always used morpholino-injected embryos 
collected later, but labeled them as 24 hpf or 48 hpf as in control.  
To ensure that this method was correct, we adopted neurogenin1 probe to stain the 
control and delayed embryos. The staining of branchial arches by neurogenin1 is a 
useful staging method. At 48 hpf, wild type embryos should fully develop 6 branchial 
arches just as shown in Fig. 3.9A. In zPin1 morpholino-injected embryos, although 
branchial arches became compressed, we can still distinguish that there were six 










Figure 3.9 Neurogenin1 staining of wild type embryos and zPin1 morphant embryos. Wild 
type embryos were collected at exactly 48 hpf (A), and zPin1 knock down embryos were 









3.3.3 Global apoptosis caused by zPin1 lost-of-function 
In addition to the developmental delay phenotype, we also examined whether 
apoptosis was affected by knocking down zPin1. To further investigate these 
phenotypes, acridine orange was adopted to detect apoptotic cells. The staining result 
in Fig. 3.10 displayed a significant increase of apoptosis signal for the whole embryo 
region, from brain to tail in morpholino injected embryos compared with that in wild 
type control embryos. The increased apoptosis is consistent with results derived from 
in vitro cell culture studies. Previous papers reported that inhibition of Pin1 function 
in human tumor cells using Pin1 antisense RNA or dominant-negative mutants 
induced mitotic arrest and apoptosis (Lu et al., 1996; Rippmann et al., 2000). 
Subsequent studies revealed interaction of Pin1 with Daxx, survivin, iASPP and Bcl2, 
thereby involving in regulating apoptosis (Basu et al., 2002; Dourlen et al., 2007; 









Figure 3.10 Global apoptosis phenotype in zPin1 morphant embryos. Wild type (A) and 
zPin1 morpholino injected embryos (B) were collected at 24 hpf. Embryos were incubated in 
the acridine orange solution. Half an hour later, the embryos were washed several times and 
observed under the fluorescence microscope. Arrows indicated the acridine orange staining.  
A WT B Pin1 MO
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3.3.4 M-phase arrest caused by zPin1 loss-of-function 
To test whether cell cycle progression was affected in zPin1 morpholino injected 
embryos, phosphorylated histone H3 (pH3) staining was applied. Histone H3 can be 
specifically phosphorylated during mitosis and has become a marker for M-phase 
cells. Wild type control embryos and zPin1 knock down embryos at 7 hpf, 25 hpf and 
48 hpf were collected and stained for pH3. When embryos developed to 7 hpf, with 
pH3 antibody, we can not detect any developmental difference between wild type 
control and loss of zPin1 function embryos on the shield area (Fig. 3.11A and B). This 
result was quite similar to embryos at 25 hpf (Fig. 3.11C and D). However, at 48 hpf, 
when delay was evident, brain region, especially the hindbrain, exhibited a significant 
increase of pH3 staining in zPin1 morphants, compared with wild type embryos (Fig. 
3.11E and F).  
The marked increase of pH3 staining for morpholino-injected embryos at 48 hpf 
indicated M phase arrest of cell cycle. As reported, various mitosis substrates of Pin1 
have been identified, such as Cdc25C, Wee1 and Emi1. Indeed, depletion of Pin1 in 
tumor cells can induce mitotic arrest (Rippmann et al., 2000). Hence, our own result 
coincided with preceding studies quite well. Besides, it was likely that developmental 
delay was induced by M phase arrest, which could prolong cell cycle. More studies 

























Figure 3.11 Phospho-H3 staining of wild type and zPin1 morphant embryos. Embryos 
were collected at 7 hpf (A, B), 25 hpf (C, D) and 48 hpf (E, F). Embryos were stained with 
pH3 antibody and photographed under confocal microscope. A, B focused on the shied area. 
C, D, E, F were all dorsal view with anterior to the left.  Arrows indicated midbrain-


















3.3.5 Neuronal phenotypes caused by zPin1 lost-of-function 
3.3.5.1 The defects on mature neurons 
Our in situ data on zPin1 expression showed intense and quite unique staining on 
the brain region. Therefore, we speculated that there were some specific neuronal 
defects for zPin1 morpholino injected embryos. To verify this hypothesis, we used 
acetylated tubulin antibody, which is a marker for all mature neuron axons, to stain 
embryos.  
The staining result is shown in Fig. 3.12. Comparing wild type control embryos 
(Fig. 3.12A and C) and zPin1 morpholino-injected embryos (Fig. 3.12B and D), it was 
found that zPin1 MO-injected embryos not only showed a decreased number of 
cranial neurons in tectum region (Fig. 3.12B, asterisk), but also displayed total lack of 
axonal projections in midbrain and defective shortened axonal tracks in hindbrain, 
with lateral view being most evident (Fig. 3.12C and D).  
We could conclude from our result that there were some neuronal defects in brain 
especially in the hindbrain region. Given the induced expression of Pin1 in neuron 
differentiation and its well-characterized role in protecting against neurodegeneration, 
we reasoned that zPin1 might play a prevalent role in neuron differentiation process 




















































Figure 3.12 The neuronal defects in zPin1 morphant embryos. Wild type (A, C) and 
zPin1 knockdown (B, D) embryos were collected at 48 h and stained with acetylated 






















3.3.5.2 The defects for neuroD expression 
To evaluate whether neuron determination process was defective, we used glial 
fibrillary acidic protein (GFAP) antibody to stain embryos. GFAP is one kind of class 
III intermediate filament that is primarily expressed in astrocytes and radial glial cells 
of central nervous system (CNS). Radial glial cells belong to neural stem cells and 
most of neurons in brain are derived, either directly or indirectly from radial glial cells 
(Malatesta et al., 2003; Anthony et al., 2004). 
The identical staining pattern in Fig. 3.13A and B indicated that early neuron 
specification or determination was not affected. Hence, we suspected that Pin1 might 
interfere with neuron differentiation process. To further characterize zPin1 
knockdown neuronal phenotypse, several markers were chosen for in situ 
hybridization analysis including: neurogenin1 (ngn1), neuroM, her4, neuroD, pax6, 
nkx2.2, isl-1 and otx2b. All staining results were demonstrated in Fig. 3.13C to T. 
neuroD was chosen because we had displayed interaction between zPin1 and NeuroD 
(Fig. 3.5B). Furthermore, NeuroD itself is a key neuron differentiation factor. After 
staining, we demonstrated that neuroD expression pattern was defective: neuroD 
transcripts were lost in midbrain and hindbrain region (Fig. 3.13I and J), suggesting 
that zPin1 may affect neuroD expression.  
Two characterized upstream positive regulators of NeuroD ngn1 and neuroM, and 
one negative upstream regulator: her4 were adopted. However, all of these markers 
were examined to show identical pattern in zPin1 wild type control and zPin1 
morpholino injected embryos (Fig. 3.13C, D, E, F, G and H).  
Since we can not identify factors responsible for neuroD transcripts defects, we 
investigated whether other specific neuron markers were affected or not. The LIM 
domain homeobox gene islet (isl-1) is a marker for motor neuron specification.                                
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The expression of nkx2.2b was restricted to lateral floor plate (LFP) that was directly 
adjacent to motoneuron domain in zebrafish. Pax6 was implicated in neuron 
differentiation as well as islet morphogenesis. It has been tested in vitro that neuroD 
can induce the activation of pax6. Enough evidence showed that both expression pax6 
and nkx2.2b were dependent on sonic hedgehog (Shh) signaling. The expression of 
otx2 occurs in the optic tectum which lies relatively lateral to forebrain and midbrain 
region. 
In situ hybridization (Fig. 3.13M to T), one more time, exhibited similar expression 
pattern in zPin1 wild type and zPin1 morphant for all these markers. That means there 
is no specific neuron group that we tested, having been affected for zPin1 knockdown 
embryos.  
To conclude, among all these markers, only neuroD transcripts were lost in 
midbrain and hindbrain region, suggesting zPin1 disrupted neuroD expression directly 
or indirectly. Therefore, we could study phenotypes in zPin1 knockdown embryos 
from this point of view.   
3.3.5.3 Neuromasts hair cells defects 
In 2006, Sarrazin et al. revelaed that knockdown of the proneural gene neuroD in 
zebrafish would abrogate hair cells specifically (Sarrazin et al., 2006). Our own result 
demonstrated interaction between zPin1 and NeuroD. Therefore, we wondered 
whether loss of zPin1 function could also affect hair cells formation. We therefore 
chose to use ET4 transgenic fish; these fish can express green fluorescence protein 
(GFP) in hair cells (Parinov et al., 2004). We injected zPin1 morpholinos into ET4 
fish and collected wild type non-injected embryos as well as zPin1 morphant catch up 
embryos corresponding to 48 hpf for the subsequent assay. These embryos were 
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subjected to GFP and acetylated tubulin staining to label hair cells as well as all 
mature axons (hair cell bodies and PLL nerve), respectively.  
In Fig. 3.14A and A’, under the view of 250 × magnification, two neuromasts could 
be detected in wild type ET4 embryos in contrast to only one neuromast in an 
equivalent trunk section of zPin1 knockdown embryos. Statistically, 90.4% of zPin1 
morphant showed a marked decrease in the number of neuromasts as shown in Table 
3.2. Specifically, severe defects can be observed for hair cells when we zoomed from 
whole neuromasts into hair cells. Generally, at 48 h, 4 hair cells can be detected under 
microscope with 500 × (Fig. 3.14B and B’) and 2000 × magnification (Fig. 3.14C and 
C’), with at least 2 of which displaying features of mature neuron (Metcalfe et al., 
1985; Dambly-Chaudiere et al., 2003). On the contrary, in zPin1 ET4 morphants, only 
one or two non-mature hair cells were present.  
In summary, zPin1 loss of function caused reduced number of neuromasts. Detailed 
investigation revealed defects of hair cells. This phenotype coincided with the 
published neuroD neuromasts defects and provided a strong phenotypic evidence for 
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Figure 3.13 Expression of marker genes in zPin1 morphant embryos. Wild type 
embryos and zPin1 morphant were collected at 48 h and analyzed for expression of 
different makers. GFAP staining (A, B), ngn1 (C, D), neuroM (E, F), her4 (G, H), 
neuroD   (I, J), pax6 (M, N), nkx2.2 (O, P), isl-1 (Q, R) and otx2 (S, T) at 100 × 
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Figure 3.14 The impaired formation of posterior lateral line neuromasts in zPin1 
morphant embryos. ET4 embryos were injected with zPin1 morpholino1 and collected at 
48 h. Wild type ET4 (A, B, C) and zPin1 morphants (A’, B’, C’) were stained with 
acetylated tubulin (red) as well as GFP (green) to show the whole lateral line and 
neuromast hair cells specifically under different magnification 250 × (A, A’), 500 × (B, 




Table 3.2: Loss of zPin1 affects lateral line hair cells development  
  Normal 
(4-6) 
Abnormal 
   (0-3) 
Total 
Wild type     72 
(94.7%) 
     4 
 (5.3%) 
76 
Pin1 morphant      8 
 (9.6%) 
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3.3.5.4 Neuromasts mantle cells defects  
To further evaluate effect of loss of zPin1 function in zebrafish, we tested zPin1 
morpholino by using ET20 transgenic fish, in which mantle cells showed green 
fluorescence. Previously, mantle cells were examined and found no defects in NeuroD 
knockdown embryos compared with wild type control embryos. Thus, neuromasts 
defects were restricted to hair cells for NeuroD morpholino injected embryos. Loss of 
zPin1 function embryos, nevertheless, showed defective GFP expression in mantle 
cell: nearly all mantle cells were lost in zPin morphant (Fig. 3.15C and D) compared 
to wild type control (Fig. 3.15A and B).  
This result was not surprising as zpin1 transcripts were distributed through the 
entire neuromast (Fig. 3.4F) which suggested its potential effect for mantle cells 
formation. Besides, it was reported previously that loss of hair cells could indirectly 
affect survival of accessory cells (Erkman et al., 1996). This provided one explanation 
for defects of mantle cells.  
 
3.3.6 The specificity of neuromasts defects  
Neurogenin 1 is a well established upstream regulator of neuroD, with regards to 
the function of neuron differentiation. However, it was reported that neuroD acted 
downstream of ath1 but not ngn1 in the case of posterior lateral line neuromasts 
formation or hair cells differentiation. Ngn1, was only responsible for development of 
lateral line placode and ganglia, for which NeuroD was not involved in (Andermann 
et al., 2002).  
Previously, we found that that there were neuromast hair cells defects in zPin1 
morpholino injected embryos. To rule out off-targets effects of zPin1 morpholino, we 
analyzed influence of zPin1 morpholinos on ganglion formation using ngn1 mutant 
Results 
 97 
fish line (mi20). In mi20 embryos, lateral line posterior ganglion was lost (Fig. 3.16A 
and B), while, for both zPin1 morphant and NeuroD morphant, ganglion was still 
present (Fig. 3.16C and D). The loss of ganglion in ngn1 mutant embryos confirmed 
previous conclusion that Ngn1 played its role in regulating ganglion formation. For 
neuromasts, our DASPEI (specific marker for hair cells) staining revealed the 
presence of hair cells (Fig. 3.16E) in ngn1 mutant. The intact morphology of hair cells 
strongly suggested that hair cell differentiation was dependent on NeuroD function 
but not Ngn1.  
Considering that zPin1 morphant shared similar neuromasts hair cells phentoypes 
with NeuroD morphant but not Ngn1 mutant, we can conclude that Ngn1 was not 

























































    
 
   
 
Figure 3.15 Accessory mantle cells phenotypes in zPin1 morphant embryos. zPin1 
morpholino was injected into ET20 transgenic line. At 48 hpf, wild type (A, B) and zPin1 
knockdown embryos (C, D) were collected and photographed under microscope at 50 × (A, 
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Figure 3.16 Posterior lateral line ganglion in mi20 embryos. Wild type (A), mi20 (B), 
nrd morpholino injected embryos (C) and zPin1 morpholino injected embryos (D) were 
collected at 48 hpf and stained with acetylated tubulin. The posterior lateral line ganglion 
was observed and photographed under confocal microscope. (E) Neuromasts were not 
affected in mi20 embryos. 48 hpf of mi20 embryos were stained with hair cells specific 
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3.4 Regulation of NeuroD stability by zPin1 
Various studies revealed that Pin1 played a universal role in regulating protein 
stability. Pin1 can stabilize cyclin D1, β-catenin, p53, NF-κB, and Emi1. On the other 
hand, Pin1 can also destabilize CF2, cyclin E, c-Myc, PML, che-1 as well as Btk as 
reviewed in the introduction part (Mantrova et al., 1998; Ryo et al., 2001; Liou et al., 
2002; Ryo et al., 2003; Dominguez-Sola et al., 2004; Yeh et al., 2006; Yu et al., 2006; 
Bernis et al., 2007; De Nicola et al., 2007; Reineke et al., 2008). Based on these 
findings, we proposed that zPin1 possibly could affect the stability of NeuroD.  
To evaluate specific effects of hPin1 on NeuroD stability, we performed a 
translation shut-off experiment in HEK 293T shRNAi control and HEK 293T stably 
expressing hPin1 shRNAi cells. Cells transfected with HA-NeuroD were treated with 
cycloheximide and the lysates were collected at 0 h, 2 h, 4 h and 8 h time point. 
Following that, cell lysates were subjected to Western blotting with anti-HA antibody 
to investigate half-life of NeuroD protein. Our results indicated that stability of 
NeuroD was significantly impaired in hPin1 knockdown cells compared with that in 
control cells (Fig. 3.17A and B). To potentiate this notion, the same experiment was 
performed on MEFs wild type and MEFs Pin1 knockout cells. The result we got was 
consistent with that in HEK 293T Pin1 knockdown cells. Fig. 3.17C demonstrated 
that in the absence of Pin1, half-life of NeuroD was shortened several folds than that 
of Pin1 control cells.  
To ensure that change in NeuroD stability was indeed loss of Pin1 effect but not a 
nonspecific effect, another similar experiment was carried out. In 293T shRNAi 
control and 293T Pin1 shRNAi knockdown cells, HA-NeuroD 5A mutant, which 
possesses only residual binding ability for zPin1, was transfected into two cell lines 
and stability experiment was repeated. As demonstrated in Fig. 3.17D, NeuroD 
Results 
 101 
stability remained the same in Pin1 knockdown cells as in wild type control cells, 
further suggesting that effects of NeuroD stability was a direct consequence of 
association between NeuroD and zPin1.  
 
3.5 Rescue of NeuroD stability by Pin1  
To further exclude non-specific reasons to affect NeuroD stability, we performed 
Pin1 rescue experiment on 293T Pin1 RNAi cells. That is, zebrafish Pin1 construct or 
adenovirus human Pin1 were introduced back into cells, together with HA-neuroD. 
As shown in Fig. 3.18A, our results demonstrated that zebrafish Pin1 can recover the 
half-life of zebrafish NeuroD to nearly wild type control level. In this assay, 
polyclonal Pin1 antibody was utilized to detect expression of zPin1 to demonstrate 
that FLAG-zPin1 protein can overcome suppressive effect of RNAi. Simultaneously, 
adenovirus hPin1 can also rescue NeuroD stability as demonstrated in Fig. 3.18B.  
It was interesting to notice that both human and zebrafish Pin1 can recover 
zebrafish NeuroD stability. As mentioned in Fig. 3.2, zebrafish Pin1 shared 79% 
identity to that of human Pin1. We also performed GST-pulldown experiment with 
human GST-Pin1 beads and our result revealed that zebrafish NeuroD was able to 
interact with human Pin1. That provided a basis to perform most of stability 
experiments on human HEK 293T cells.  
Due to our failure to rescue hair cells defects, it was especially of significance to 
restore NeuroD protein level in cells. From this experiment, we could infer that loss of 










































































































































Figure 3.17 The increased stability of NeuroD mediated by zPin1. (A) NeuroD had a 
shorter half-life when Pin1 level was decreased. HA-neuroD was transfected into 293T wild 
type and Pin1 knockdown cells. After 24 hours, cells were treated with cycloheximide. The 
treated cells were harvested at indicated time points 0 h, 2 h, 4 h and 8 h. The cell lysis was 
subjected to anti-tubulin, anti-Pin1 and anti-HA antibodies. (B) The graph compared 
stability of transfected NeuroD in HEK 293T wild type control as well as Pin1 shRNAi 
cells. 0, 2, 4, 8 on X axis represented the hours after cycloheximide treatment. The ratio of 
NeuroD density band to tubuin band was plotted at Y axis. The ratio for zero time point was 
calculated as 1. (C) NeuroD was shown to degrade at a higher rate in Pin1 knockout MEFs 
cell line. The experiment was performed as described in A. (D) HA-neuroD 5A was stable 
in Pin1 knockdown cells. HA-neuroD 5A was introduced into 293T control and Pin1 
knockdown cells. The stability experiment was performed as A and B.  
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Figure 3.18 The recovery of NeuroD half-life by re-introduction of Pin1. (A) 
Overexpression of zebrafish origin FLAG-Pin1 enhanced NeuroD stability. In 293T 
Pin1 knockdown cells, zebrafish FLAG-Pin1 was transfected into cells together with 
HA-NeuroD. 24 h later, cycloheximide was added and cell lysates were collected at 0 h, 
2 h, 4 h and 8 h. Anti-HA, anti-tubulin and anti-FLAG antibodies were used for Western 
blotting.  (B) Overexpression of human Pin1 rescued NeuroD stability. 293T Pin1 
knockdown cells were transfected with HA-NeuroD. At the same time, human 
adenovirus Pin1 was added into medium for infection. Stability assay was then 




3.6 The effects of zPin1 on insulin gene expression 
The best studied NeuroD function is its regulation on insulin gene transcription 
(Chae et al., 2004). It would be rather difficult if we have to investigate zPin1’s 
function from this aspect, because insulin regulation is quite a complicated process. In 
zebrafish embryos, zPin1 transcripts cannot be detected in any of endoderm-derived 
organs such as liver and pancreas because zPin1 expression was only restricted to 
brain and neuromasts as shown in Fig. 3.4. Hence, zPin1 should have no effect, for 
early pancreas development and further on insulin gene transcription. 
To confirm this statement, we adopted mi20 embryos to study insulin gene 
transcripts. In mi20 embryos, only ganglion is lost with all the other features being 
normal. With regards to insulin expression level, it is the same in mi20 embryos as 
well as in wild type embryos. We injected mi20 embryos with zPin1 morpholinos and 
performed analysis 48 hpf. In situ hybridization staining for insulin probe clearly 
showed that insulin transcripts can be detected in zPin1 morphant. Although the 
staining area became smaller (Fig. 3.19A and B), it seemed quite proportional to 
embryo size. Similar results were derived from insulin transgenic line (Fig. 3.19C and 
D). This transgenic fish line can express green fluorescent protein under the control of 
insulin gene regulatory sequence so as to resemble expression of insulin mRNA. 
Furthermore, we used RT-PCR to detect insulin gene transcription. Wild type and 
zPin1 morpholino injected embryos were collected at 24 h and analyzed for its insulin 
gene expression (Fig. 3.19E). As expected, level of transcripts remained the same.   
All results in Fig. 3.19 confirmed our hypothesis that there was no correlation 
between zPin1 and insulin gene regulation. Therefore, we can exclude the possibility 









































Figure 3.19 Pancreas insulin gene transcripts in zPin1 morphant embryos. 48 h wild 
type mi20 embryos (A) and zPin1 knockdown mi20 (B) were analyzed with insulin probe. 
(C, D) Insulin transgenic zebrafish embryos were injected with zPin1 morpholino and 
observed under them microscope. (E) Wild type and zPin1 knockdown embryos were 
collected to extract mRNA. Later, RT-PCR was carried out with EF-1α as the loading 
control.  
insulinA insulinB
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Chapter 4 Discussion and Conclusion 
Pin1 can regulate functions of various molecules by catalyzing their conformational 
changes. More than 50 substrates of Pin1 have been isolated since the discovery of 
Pin1. Pin1 is involved in cell cycle regulation, apoptosis, immune response as well as 
neuron degeneration (Lu, 2004; Wulf et al., 2005). Indeed, all neuronal phenotypes 
were derived from Pin1 knock-out mice and were age-dependent neurodegeneration 
(Liou et al., 2003). However, the role of Pin1 in early development is nearly 
untouched.  
The main aim of my thesis research was to explore function of Pin1 in development 
using zebrafish as model system. During the course of these studies, we found that 
zPin1 loss of function embryos displayed several interesting phenotypes. Considering 
time constraint on characterizing all phenotypes, we therefore mainly focused on 
characterization of Pin1 function in central nervous system of zebrfish development. 
To unravel the mechanism, we also identified a novel substrate of zebrafish Pin1, 
NeuroD, which is a bHLH family transcription factor essential for neuron 
differentiation and insulin secretion (Chae et al., 2004). To further investigate 
relationship between zPin1 and NeuroD, we carried out a series of molecular 
biological and biochemical experiments. Detailed discussion will be described in 
subsections below 
 
4.1 Molecular analysis of zebrafish Pin1  
To address role of zPin1 in zebrafish development, we performed blast search 
against zebrafish GeneBank using human Pin1 ORF as the template. We can retrieve 
several ESTs of zebrafish Pin1. However, these ESTs were just deposited in the bank 
and have not been reported in any papers. To gain more insights into zebrafish Pin1 
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gene, we carried out RACE to verify full length of zPin1. Meanwhile, RT-PCR and 
Western blotting were accomplished to examine expression pattern of zPin1. 
RACE experiment revealed that full length of zPin1 was 899 bp long with 81 bp of 
5’-UTR, 342 bp of 3’-UTR and 477 bp of coding region. RT-PCR result showed that 
zpin1 mRNA expression was constant from one cell stage through the first 3 days, 
revealing essential roles of zPin1 in early development of zebrafish. Western blotting 
assay demonstrated zPin1 protein level in various tissues. Consistent with data 
derived in previous mouse model, a higher zPin1 expression level was detected in 
brain and testis, suggesting that zPin1 may be involved in regulating development of 
the two tissues (Liou et al., 2002). Indeed, Pin1-null mice developed age-dependent 
neurodegeneration with evident motor and behavioural defects (Liou et al., 2003). 
Pin1 was also reported to affect proliferation of mammalian primordial germ cells by 
prolonging cell cycle length. As a result, testis of adult Pin1-null mice had a 
progressive depletion of spermatogonia with eventual total loss of germ cells 
(Atchison et al., 2003; Atchison et al., 2003).  
Besides expression pattern, we were surprised to find that two zPin1 bands can be 
detected in muscle tissue from our Western result, with one band having regular 
molecular weight (18 kDa) and another band indicating higher molecular weight. 
In mammals, a human Pin1 isoform (Pin1L) was identified. This isoform only 
contained WW domain fused to a 37 amino-acid tail and was non-functional 
(Campbell et al., 1997). Recently, Zhu et al. isolated a novel murine Pin1 isoform 
(mPinlL) that contained both WW domain and PPI domain. This novel Pin1 isoform 
possessed only one fourth of the ability to catalyze cis/trans isomerization compared 
with wild type Pin1 (Zhu et al., 2007). The molecular weight of those two reported 
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isoforms is smaller or nearly identical to that of wild type ones. Thus far, in 
vertebrates, there was no longer Pin1 isoform having bee identified.  
Therefore, it is tempting to identify Southern analysis (Fig. S.2) showed that there 
was only one gene copy of Pin1 in zebrafish genome. Consequently, to examine 
whether there is Pin1 isoform in zebrafish, experiments such as Northern blotting and 
muscle specific RACE may be needed.  
This is the first time that zPin1 full length has been cloned. Furthermore, its spatial-
temporal expression pattern in zebrafish embryos was characterized. It turned out that 
zPin1 shared a high similarity with human Pin1 and mouse Pin1 (Fig. 3.2B) (Lu et al., 
1996). This conservation suggested that our studies in fish may be valuable to Pin1 
studies in mouse and human in the future.  
 
4.2 The effects of zPin1 morpholinos 
To study gene functions in vivo, one direct and efficient way is to inhibit this gene 
specifically and analyze loss of function phenotypes. Conventionally, people adopted 
antisense RNA, antisense oligonucleotides as well as RNAi to knock down gene 
function. However, all these techniques did not succeed when applied to zebrafish 
model, mostly due to non-specific effects (Oates et al., 2000).  
Morpholinos are a chain of oligonucleotides comprising about 25 morpholino 
subunits. Each subunit is similar to DNA or RNA with the exception of a morpholine 
ring. Since its discovery, MOs-mediated gene targeting has become a routine method 
to knockdown specific gene expression in zebrafish (Ekker et al., 2001). Morpholinos 
can be designed to block translation of target protein or to inhibit pre-mRNA splicing. 
As other gene targeting techniques, the effectiveness and specificity of MOs are 
essential issues for use of MOs. To solve these problems, several approaches can be 
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considered. Firstly, several morpholinos are necessary. It has been recommended that 
two of them should be targeted against protein translation and another two might 
block pre-mRNA splicing (Eisen et al., 2008). For our study, in terms of failure to 
find any introns for zPin1 gene, we can only design morpholinos targeting translation 
initiation sites and 5’-UTR to disrupt protein translation, respectively. Both of the two 
morpholinos have been tested with Pin1 antibody, it showed that Pin1 level was 
indeed decreased (Fig. 3.7). Secondly, the use of control morpholino is required. In 
our own assay, we used “Standard Control” MO provided by the company (Gene 
Tools, USA). Control injected embryos did not display any phenotypes. Furthermore, 
RNA rescue is the most reliable method to confirm specificity of morpholino. We 
succeeded in performing rescue on cell lines.  
 
4.3 Developmental delay caused by zPin1 knockdown 
zPin1 loss of function embryos were delayed for their developmental progression 
as revealed in Fig. 3.8. This developmental delay could be attributed to two reasons: 
increased apoptosis or decreased proliferation. To determine which one is the main 
factor, we performed pH3 assay and acridine orange staining.  
Phospho-H3 assay identified mitotic phase arrest in zPin1 morphant embryos as 
shown in Fig. 3.11, which may provide one of the reasons to explain retardation of 
development process. In fact, Pin1 was initially identified as a mitotic regulator and 
its role in mitosis was demonstrated in budding yeast, Xenopus, as well as mammals 
with many mitotic substrates identified. Among all these substrates, the most well 
studied were Cdc25C, Wee1 and Emi1 (Yaffe et al., 1997; Bernis et al., 2007; 
Okamoto et al., 2007). All these factors are critical for mitosis entry. It has been 
demonstrated that depletion of Pin1 in HeLa cells and budding yeast could lead to 
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mitotic arrest and these mitotically arrested cells were likely to be induced by 
premature entry into mitosis followed by mitotic disaster (Krek et al., 1991; Shen et 
al., 1998). Therefore, our own results are consistent with those in vitro cell cycle 
studies.  
Besides Pin1’s function on M phase, previous in vitro cell studies also indicated 
that Pin1 knockout MEFs displayed defects in G0-G1 and G1-S transition, suggesting 
that Pin1 plays an important role in G1 and S phase of cell cycle (Fujimori et al., 
1999). For the underlying mechanism, Pin1 was reported to be involved in regulating 
cyclin D1 and cyclin E, both of which were essential factors for G1/S progression 
(Ryo et al., 2001; Yeh et al., 2006). Furthermore, Pin1 has been shown to localize to 
centrosome and its ablation can delay centrosome duplication (Suizu et al., 2006). 
Taken together, Pin1 plays a major role in G1/S transition and S phase. Therefore, it is 
highly possible that after zPin1 morpholino injection, embryos can also be arrested in 
S phase of cell cycle. To test this hypothesis, it would be helpful to stain embryos 
with BrdU (5-bromo-2-deoxyuridine), an S phase cell proliferation marker, to detect 
whether S phase is defective in vivo in the future. 
In addition to the proliferation defects, acridine orange staining revealed that 
apoptosis was enhanced in zPin1 knockdown embryos as shown in Fig. 3.10. Indeed, 
this apoptosis phenotype has been described in 1996 when Pin1 was originally 
identified. Lu et al. reported that depletion of Pin1 can lead to mitotic arrest as well as 
apoptosis in HeLa cells and budding yeast (Lu et al., 1996). In that paper, one thing 
worthy to be mentioned was that nuclear fragmentation was shown to follow the 
mitotic arrest. On the contrary, Rippmann et al. carried out apoptosis assay to reveal 
that in tumor cells, apoptosis occurred in interphase but not mitosis (Rippmann et al., 
2000). In conclusion, apoptosis could be caused by arrest in interphase or mitosis.  
Discussion and Conclusion 
 112 
Moreover, Pin1 was able to bind with Daxx (The death-associated protein), which 
was identified as binding partner of death domain of Fas ligand and facilitated Fas-
mediated apoptosis (Yang et al., 1997; Ryo et al., 2007). The interaction between 
Pin1 and Daxx can protect against Daxx-mediated apoptotic response.  
In contrast, Pin1 can interact with and stabilize p53 to promote p53-dependent 
apoptosis. Therefore, in Pin1 knockout MEF cells, the number of apoptosis cells was 
reduced to half compared to wild type cells under UV irradiation (Zacchi et al., 2002). 
In addition, Pin1 was shown to downregulate an inhibitor of apoptosis protein-
survivin or help antiapoptotic Bcl-2 to keep in its active state. For all these cases, Pin1 
depletion can cause an increase of apoptosis (Pathan et al., 2001; Basu et al., 2002; 
Dourlen et al., 2007). 
Collectively, we can infer that Pin1 has opposite roles in apoptosis process 
depending on the context. Our results are consistent with the role of Pin1 in negative 
regulation of apoptosis. It is attractive to identify novel regulators of Pin1 related to 
apoptosis in development.  
 
4.4 The interaction between zPin1 and NeuroD 
We showed strong interaction of zPin1 with NeuroD by both in vitro GST pull-
down assay and in vivo co-immuoprecipitation experiment (Fig. 3.5 and Fig. 3.6). In 
addition, CIAP and NeuroD mutant binding experiments (Fig. 3.6A) demonstrated 
that binding between zPin1 and NeuroD was dependent on the phosphorylation of 
NeuroD.  
There are five Ser/Thr-Pro motifs on NeuroD (Fig. 4.1). In previous studies, ERK 
was identified as upstream kinase for Ser162, Ser259, Ser266 and Ser274 sites; 
GSK3β was the kinase to phosphorylate Ser274 in Xenopus NeuroD (Marcus et al., 
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1998; Moore et al., 2002; Khoo et al., 2003).  Therefore, we chose corresponding 
sites on NeuroD: Ser157 (parallel to Ser162), Ser259 (parallel to Ser266) and Ser267 
(parallel to Ser274) for mutation. Subsequently, we used single and double mutants of 
NeuroD for pulldown assays to examine the importance of these potential 




Figure 4.1 Xenopus versus zebrafish NeuroD protein sequence alignment. The four 
serines mapped by Khoo et al., Ser162, Ser259, Ser266, and Ser274, as well as the residue 
immediately following these serines are boxed with red columns (Khoo et al., 2003). 
Zebrafish Thr218 and Ser223 are circled in light blue.  
 
 
All the NeuroD single and double mutants were able to interact with zPin1 and did 
not exhibit any difference for their zPin1 binding ability in comparison with that of 
wild type NeuroD (Fig. 3.6B and C). To further investigate other phosphorylation 
sites, we generated 3A mutant of NeuroD and performed binding assay. It turned out 
that the interaction ability was reduced, but only to a minor extent (Fig. 3.6D). We 
then further generated 4A mutant of NeuroD by mutating the remaining two Ser/Thr 
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sites (Thr218, Ser223) although there have been no reports on kinases responsible for 
their phsophorylation. Both of the two 4A NeuroD mutants demonstrated a 
comparable decrease with zPin1 binding (in comparison with 3A mutant, Fig. 3.6D). 
Finally, NeuroD mutant with Ser-to-Ala substitutions on all five Ser/Thr-Pro motifs 
(5A) showed a significant reduced binding to zPin1 (Fig. 3.6E), suggesting that the 
interaction between NeuroD and zPin1 depends on the synergistic effect of multiple 
Ser/Thr-Pro motifs, but not any particular one. 
Although some residual interaction between zPin1 and NeuroD remained even 
when all five potential zPin1 binding sites were mutated to alanines (Fig. 3.6E), this 
was not the exception since p53 and p73 similarly maintained trace binding to their 
substrates after having all S/T-P sites mutated (Zheng et al., 2002; Oberst et al., 2005).  
However, this residual binding suggests that zPin1 could potentially bind NeuroD 
via other sites. Indeed, Pin1 was shown to be able to isomerize Glu-Pro containing 
peptides, albeit at a relatively slower rate than pSer/Thr-Pro containing peptides 
(Yaffe et al., 1997). The negative charge of glutamic acid may mimic negative charge 
of phosphate groups and allows for interaction with Pin1 (Petersen et al., 2002). In 
NeuroD, three Glu-Pro sites: E39, E247 and E281 may function as binding motifs to 
interact with zPin1.  
Taken together, these data demonstrate that phosphorylation of Ser/Thr residues is 
important for interaction between NeuroD and all five Ser/Thr-Pro motifs on NeuroD 
are critical for this interaction with zPin1. Further studies are needed to address the 
question on how these five residues act synergistically to bind with zPin1.   
 
4.5 Protein stabilizing effect of NeuroD by zPin1 regulation 
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Our stability assay showed that Pin1 can stabilize NeuroD because in both Pin1 
knockdown 293T cells and Pin1 knockout MEFs cells, overexpressed NeuroD had a 
shorter half-life compared to that in wild type cells. Mechanism will be discussed as 
follows.  
With in vitro GST binding assays, we demonstrated that zebrafish NeuroD can 
interact with human Pin1 (Appendices). This is not surprising as zebrafish Pin1 and 
human Pin1 are quite conserved, sharing 79% sequence identity (Fig. 3.1). This result 
provided the basis for our later stability study in human HEK 293T and mouse MEFs 
cells.  
In both 293T Pin1 knockdown cells and MEFs Pin1 knockout cells, we 
demonstrated that exogenous NeuroD had a shorter half-life, suggesting that Pin1 may 
act to stabilize NeuroD. Furthermore, re-introduction of either zebrafish Pin1 (Fig. 
3.17C) or human Pin1 (Fig. 3.17D) recovered NeuroD protein level in Pin1 
knockdown and knockout cells. This rescue strongly supports a notion that the 
stabilization is a direct consequence of interaction between NeuroD and zPin1. 
Work by other investigators indicated that Pin1 can affect protein level of various 
substrates, positively or negatively. Pin1 can increase stability of those substrates such 
as cyclin D1, NF-κB, β-catenin, Emil, p53, p73, Mcl-1, BimEL and HBx (Ryo et al., 
2001; Liou et al., 2002; Zacchi et al., 2002; Ryo et al., 2003; Mantovani et al., 2004; 
Becker et al., 2006; Bernis et al., 2007; Datta et al., 2007; Seo et al., 2007). On the 
other hand, Pin1 can decrease stability of some proteins including c-Myc, SRC-
3/AlB1, cyclin E, Daxx, Survivin, CF2, IRF3, BTK, Che-1 and PML (Hsu et al., 2001; 
Yeh et al., 2004; Saitoh et al., 2006; Yeh et al., 2006; Yu et al., 2006; De Nicola et al., 
2007; Ryo et al., 2007; Reineke et al., 2008). Based on what we have shown in this 
study, NeuroD may now be added to the first group of substrates. 
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Pin1 can increase stability of its substrates through several mechanisms. Pin1 can 
bind to phosphorylated form of some specific targets and prevent their nuclear export 
to cytoplasm, where they would be degraded through ubiquitin-proteasome pathway. 
Cyclin D1, NF-κB and β-catenin belong to this category.  
Pin1 can also increase stability of its targets by inhibiting their binding to ubiquitin 
E3 ligase such as MDM2 for p53, βtrcp for Emi1 and SOCS-1 for p65 subunit of NF-
κB (Zacchi et al., 2002; Ryo et al., 2003; Bernis et al., 2007). p73 is an exception. 
Pin1 can bind to phosphorylated p73, catalyze conformational changes and facilitate 
acetylation by p300 which will lead to accumulation and stabilization of p73 (Oberst 
et al., 2005).  
However, the mechanism of Pin1’s stablilizing effect on other substrates still 
remains elusive. In case of BIMEL and Mcl-1, Pin1 can interact with phosphorylated 
BIMEL and Mcl-1 to prevent ubiquitin-dependent proteasome degradation (Becker et 
al., 2006; Seo et al., 2007). But the exact E3 ligase involved has not been identified.  
Thus, all indications suggest that Pin1 acts as a molecular switch on its targets to 
either prevent or promote degradation through ubiquitination. Herein, according to 
our observations, NeuroD could be stabilized by zPin1. However, in our study, we did 
not address the mechanism of NeuroD stabilization by zPin1. To date, no data is 
available with regards to NeuroD degradation. We speculate that NeuroD 
phosphorylation may regulate protein stability by targeting it for ubiquitin-mediated 
degradation. This strategy of degradation is adopted by two other bHLH factors, 
MyoD and Neurogenin1. MyoD belongs to a family of skeletal muscle-specific bHLH 
transcription factors and Neurogenin1 is a well-characterized NeuroD regulator. It has 
been demonstrated that phosphorylation promoted their degradation via ubiquitin-
mediated proteasome pathway (Song et al., 1998).   
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Therefore, we hypothesize that binding of zPin1 with phosphorylated NeuroD may 
also regulate NeuroD stability by disrupting ubiqitin-mediated proteolysis pathway by 
interfering with binding of specific E3 ligase as p53, Emil and NF-κB.  
Moreover, it has been shown in Xenopus that over-expression of S266A and S277A 
mutants led to protein accumulation in embryos (Dufton et al., 2005). In other words, 
non phosphorylated form of NeuroD might be more stable. It is also possible that 
specific serine phosphorylation on NeuroD could influence its interaction with other 
proteins; thereby creating a complex that is more susceptible to protein degradation 
(Dufton et al., 2005). Specifically, zPin1, as the binding partner of phosphorylated 
NeuroD, could potentially facilitate dephosphorylation of NeuroD. The effect of 
cis/trans isomerase Pin1 on phosphorylation status of target proteins has been well 
studied in PP2A. PP2A is a major Pro-directed phosphatase. The function of PP2A is 
conformation-specific and effectively dephosphorylates only trans pSer/Thr-Pro 
isomer (Zhou et al., 2000). Pin1 has been shown to catalyze prolyl isomerization of 
specific pSer/Thr-Pro motifs in Cdc25C and tau to facilitate their dephosphorylation 
by PP2A (Zhou et al., 2000; Hamdane et al., 2006). Thus, in the case of NeuroD, 
zPin1 may act similarly by converting pSer/Thr-Pro motifs of NeuroD into the trans 
conformation for its dephosphorylation by PP2A to prevent NeuroD translocation and 
degradation.   
 
4.6 The specificity of neuromasts defects 
Zebrafish embryos exhibited neuromasts defects after zPin1 has been knocked 
down. Neuromasts belong to the posterior lateral line system (PLL). The PLL is made 
up of two cell populations: PLL ganglion and lateral line neuromasts (Metcalfe et al., 
1985; Gompel et al., 2001). Neuromasts are composed of three types of cells: central 
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hair cells, inner accessory cells (support cells) and outer accessory (mantle) cells 
(Jones et al., 1993; Ledent, 2002).  
Tol2 transposon mediated enhancer trap lines were previously created by Parinov et 
al. in 2004 (Parinov et al., 2004) (database website: http://plover.imcb.a-
star.edu.sg/~zetrap/ZETRAP.htm).  Sarrazin et al. employed one of these lines, ET4 
(GFP expression in hair cells), to demonstrate the loss of neuromast hair cells in their 
manipulation of nrd and ath1 (Sarrazin et al., 2006). Here, we employed ET4 and 
ET20 (with GFP expression in mantle cells) for zPin1 loss-of-function analysis. In 
zPin1 morphant, both hair cells and mantle cells were defective, suggesting that the 
role of zPin1 is more general than specification of neuromast hair cells alone. In view 
of the role of Pin1 in cell cycle regulation, we are currently unable to definitively 
differentiate between cell proliferation defects and specification defects in 
development of neuromasts. 
However, pulldown assay indicated that zPin1 and NeuroD can interact with each 
other physically. In vitro studies also demonstrated that loss of zPin1 can decrease 
NeuroD protein level (Fig. 3.17A, B and C). Hence, even if zPin1 indeed played a 
role in proliferation of hair cell progenitors, it could still have a role further on 
specification of neuromasts hair cells by regulating NeuroD level.  
The “gold standard” of analyses involving morpholino oligonucleotides is the 
“rescue”, whereby one or more phenotypes obtained from MO knockdown are 
alleviated by the co-injection of mRNAs that do not contain MO binding sites (Eisen 
et al., 2008). We made numerous attempts to rescue neuromasts defects arising from 
zPin1 MO, but have failed to do so. The failure to rescue may be attributed to the 
following: 
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Firstly, Pin1 was involved in a variety of biological processes: cell cycle, apoptosis, 
neurodegeneration, germ cell development. The multiple function of a specific gene is 
called pleiotropic effect which possibly is the main reason for failure of rescue. The 
case is same with the unsuccessful rescue of fz7 and cyclops gene (Sampath et al., 
1998; Fong et al., 2005). 
Secondly, we performed rescue experiment by co-injecting fixed amount of 
morpholino with varying amount of zpin1 mRNAs. However, there is an upper limit 
for amount of zpin1 mRNA that we can inject because excess mRNA can cause toxic 
effects such as global apoptosis, curved trunk as well as edema (data not shown). We 
can only perform rescue experiment by injecting zpin1 mRNAs below that limit. 
Therefore, the translated protein from zpin1 mRNA may not be enough to compensate 
for loss of zPin1.  
It is noteworthy that nrd expression in the PLL neuromasts can only be detected 
under less stringent conditions (Sarrazin et al., 2006), suggesting that trace amount of 
NeuroD is sufficient to control determination of hair cells. Since the dosage required 
for zPin1 knockdown to achieve the loss of neuromasts hair cells is relatively high, 
the interaction of zPin1 with NeuroD must be rather inefficient. But the consequence 
of this weak interaction is that rescue of NeuroD function with exogenous zpin1 on 
top of zPin1 MO background is technically challenging. Fortunately, we succeeded in 
performing rescue on cell lines. In HEK 293T Pin1 shRNAi cells and MEFs Pin1 
knockout cells, re-introduction of Pin1 could restore NeuroD protein levels (Fig. 3.18).  
Injection of zPin1 MO, in addition to hair cells, also led to loss of mantle cells as 
demonstrated with ET20 line. The loss of both hair cells and mantle cells in 
neuromasts may be linked. In 1996, Erkman et al. reported that absence of hair cells 
could lead to cell death of support cells. As a result, the integrity of entire neuromast 
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is dependent on the presence of hair cells (Erkman et al., 1996). However, we can not 
rule out a potential role for zPin1 in mantle cells development. Expression pattern 
comparison between zPin1 and other bHLH factors in mantle cells should reveal 
potential zPin1 targets.  
Previous studies have shown that bHLH factor Ngn1 does not play a role in hair 
cell development (Andermann et al., 2002). In this study, we showed that zPin1 can 
not interact physically with Ngn1 in pull down assays (data not shown). Moreover, 
Ngn1 mutant has no defect in neuromasts development. Instead, Ngn1 mutant 
displayed defects in development of posterior lateral line ganglian, which is not 
affected in zPin1 and Nrd morphants (Fig. 3.19). 
   NeuroD is expressed in developing pancreas, and has been demonstrated to be 
essential for specification of islet cells (Naya et al., 1995; Dumonteil et al., 1996). 
Crucially, zPin1 is not expressed in pancreas. We showed that pancreas developed 
quite normally in zPin1 morphants, suggesting that zPin1 MOs only had effects where 
zpin1 gene was normally expressed. Thus, we are confident that phenotypes 
investigated in this study are indeed on target and specific to the interaction between 
zPin1 and NeuroD.  
 
4.7 Transcriptional activity of NeuroD mediated by zPin1 
We showed that zPin1 increased NeuoD protein stability, which was dependent on 
binding of zPin1 with phosphorylated Ser/Thr-Pro motifs on NeuroD.  
Phosphorylation of NeuroD has been demonstrated in neuronal cells as well as in 
pancreatic beta cells (Khoo et al., 2003; Dufton et al., 2005). Several lines of 
evidences point to the importance of NeuroD phosphorylation on the control of its 
transcriptional activity during insulin gene activation and neurogenesis (Marcus et al., 
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1998; Moore et al., 2002; Dufton et al., 2005). We will focus on discussing the impact 
of NeuroD phosphorylation on neurogenesis.   
Both GSK3β and ERK have been shown to phosphorylate NeuroD (Marcus et al., 
1998; Moore et al., 2002; Khoo et al., 2003; Dufton et al., 2005). Xenopus NeuroD is 
phosphorylated on Ser274 by GSK3β. This phosphorylation inhibits NeuroD activity, 
thereby negatively regulating neuronal differentiation by inhibiting NeuroD activity 
(Marcus et al., 1998). Neurogenesis assay in Xenopus embryos revealed that 
overexpression of GSK3β inhibited formation of N-tubulin-positive neuronal cells, 
while expression of dominant-negative kinase-dead form of GSK3β expanded this 
population (Marcus et al., 1998). 
Moreover, it was shown that mouse NeuroD which lacked complete GSK3β 
consensus phosphorylation site was not inhibited by GSK3β phosphorylation (Moore 
et al., 2002). In this respect, the integrity of GSK3β consensus phosphorylation site 
was critical for regulating neuroD phosphorylation (Moore et al., 2002). Given that 
consensus phosphorylation motif (SPPLSVNGN) for GSK3β also exists in zebrafish 
neuroD (Fig. 4.1), it is likely that GSK3β plays a role in regulating activity of 
phosphorylated NeuroD.  
On the other hand, it was shown that Ser162, Ser259, Ser266 and Ser274 can be 
phosphorylated by ERK2 (Khoo et al., 2003). However, the effect of phosphorylation 
may be opposite in a context-dependent manner. S266A and S274A mutant can 
inhibit the ability of M-NeuroD to activate insulin gene in pancreatic beta cell line, 
while the same mutant forms of X-NeuroD displayed significantly increase abilities to 
form ectopic neurons (Khoo et al., 2003; Dufton et al., 2005).  
It is noteworthy to mention that Ser274 is subjected to phosphorylation by both 
GSK3β and ERK. Sequence analysis revealed that Ser274 lied within the ERK and 
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GSK3β consensus phosphorylation site (Fig. 4.1). The phosphorylation by two 
kinases may mediate opposite effects as mentioned above. Sequence alignment also 
revealed that Ser266 and Ser274, which are in the transactivation domain of Xenopus 
and mouse NeuroD are represented by Ser259 and Ser267 in zebrafish NeuroD (Fig. 
4.1). Therefore, zebrafish NeuroD may also undergo similar phosphorylation 
regulation for its activity and protein stability.  
It has been shown that phosphorylation of NeuroD itself can promote the formation 
of neuroD/E47 heterodimer to enhance its transcriptional activity towards the insulin 
gene (Khoo et al., 2003). This activation can further be potentiated by the binding of 
p300/CREB coactivator, which has intrinsic histone acetyltransferase activity 
(Giordano et al., 1999). The recruitment of p300/CREB can increase acetylation of 
NeuroD by p300-associated factors (Qiu et al., 2004). 
Pin1 can regulate transcriptional activity of several substrates with the help of p300. 
Pin1 promotes and increases recruitment of p300 to p53, Stat3 (signal transducer and 
activators of transcription 3), SRC (steriod receptor coactivator) and p73 (Mantovani 
et al., 2004; Yi et al., 2005; Lufei et al., 2007). Consequently, Pin1 is capable of 
promoting acetylation of these targets and enhancing their transcriptional activity.   
Thus, we hypothesize that interaction between zPin1 and NeuroD probably has the 
same influence as regulating p73, p53, Stat3 and SRC. Pin1 may facilitate the 
recruitment of CBP/p300 coactivator to NeuroD and enhance its transcriptional 
activity. It has also been shown that CBP can associate with NeuroD in a 
phosphorylation-dependent manner (Sharma et al., 1999; Dufton et al., 2005). This 
hypothesis may be tested in the future. 
 
4.8 The expression of marker genes in zPin1 morphants 
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NeuroD was first identified in 1995 and was shown to be expressed in 
differentiating neurons in mice and frogs. Overexpression of neuroD led to convertion 
of non-neuronal ectodermal cells into fully differentiating neurons, suggesting that 
neuroD was a potent neuron differentiation factor (Lee et al., 1995).   
Furthermore, in adult brain, neuroD expression was also detected in mature 
neurons of cerebellum, hippocampus and olfactory bulbs. Detailed studies on 
NeuroD-null mice revealed granule cells defects in cerebellum and hippocampus, 
confirming the critical role of NeuroD in post-natal neurogenesis (Miyata et al., 1999; 
Kim et al., 2001).  
In our result, besides the neuromasts phenotype, acetylated tubulin antibody 
staining on embryos clearly displayed neuronal defects in hindbrain region (Fig. 3.12). 
To further characterize mechanism underlying that, we looked into whole neuron 
differentiating process. The nervous system derives from ectoderm by inductive 
signals emanating from mesoderm. The initial region of neural ectoderm is called 
neural plate. After undergoing shaping, folding, elevation and convergence, neural 
plate will form neural tube. The ventricular zone (VZ) of neural tube is where 
neuronal precursors proliferate. Upon the last division, those neuronal precursors exit 
from cell cycle and migrate away from ventricular zone to enter the pial side of neural 
tube for differentiation (Campos-Ortega 1995). 
 During this process, neurogenin1 is expressed in the proliferative zone. The 
vertebrate achaete-scute (ac-sc) homologue: Mash1 is also expressed by proliferating 
neuroblasts (Johnson et al., 1990; Guillemot et al., 1993). In contrast, NeuroM 
(zebrafish zath3/neuroD4) positive cells are postmitotic cells that have just left 
ventricular zone but have not yet started their migration to outer layers, known as the 
premigratory cells layer. In comparison, NeuroD labels neurons which are migrating 
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or have reached their final position. This process is summarized in Fig. 4.2 (Roztocil 




Figure 4.2 bHLH genes expression during neurogenesis.  During the process of 
neurogenesis, ventricular zone (VZ) of neural tube is where proliferation of neuronal 
precursors occurs.  In VZ, cells undergo asymmetric division with one cell remaining in the 
proliferative zone and the other migrating away to the outer layers. Proliferating progenitors 
express some helix-loop-helix transcription factors such as ASH1, Neurogenin, HES1. 
Among them, HES1 is an inhibitory factor that keeps progenitors in a proliferative and 
undifferentiated state. Activators (ASH1 and Neurogenin1) can promote neuronal 
differentiation. Upon the last division, precursors exit from cell cycle and migrate away from 
VZ to the pial side. NeuroM is expressed when these postmitotic cells just left the VZ but not 
start to migrate. In contrast, neuroD labels those migrating cells. NeuroM is shown to activate 
neuroD.  (This figure was adapted from Roztocil et al., 1997) 
 
 
Among neuroD and three of its upstream regulators: neurogenin1, her4 and 
neuroM; only neuroD expression was abnormal. Therefore, loss of neuroD may be 
the reason for hindbrain defects. Although pulldown experiment demonstrated 
interaction between zPin1 and NeuroD, and zPin1 could stabilize NeuroD, we can not 
demonstrate binding of zPin1 with Neurogenin1, an essential regulator of NeuroD. 
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While Ath1 can interact with zPin1, there is no evident phenotype for ath1 mutant 
fish (data not shown). It would be desirable to test for physical interaction between 
zPin1 and other known bHLH factors in the cascade. Regrettably, we have to halt our 
investigation due to time constrain. 
A possible explanation for lost of neuroD transcript is that NeuroD protein may 
regulate the expression of itself. Promoter sequence analysis of mouse neuroD in 
2000 revealed that E1 and E4 boxes could potentially be NeuroD binding regions. To 
test this assumption, neuroD and its promoter region were co-transfected into 
neuroblastoma cell line and this transfection enhanced neuroD promoter activity by 
several folds (Miyachi et al., 1999; Huang et al., 2000).  
Specific neuron markers downstream of neuroD such as pax6, islet-1 and otx2b 
(Fig. 3.13) did not show any defects in their expression. This may be the consequence 
of a redundancy in NeuroD function in these tissues in zebrafish. However, it should 
be noted that NeuroD null-mice did not display motor-neuron defects too (Miyata et 
al., 1999).  
Except NeuroD, there is a bit increase of expression level for those left marker 
genes transcripts although we demonstrated that their expression pattern did not 
change in zPin1 morphant embryos compared with that in wild type embryos. The 
difference might be revealed if Q-PCR method is applied. However, due to easier 
penetrance of morphant embryos, it is reasonable that they demonstrate an elevated 
expression level.  
 
4.9 Pin1 as a novel regulator of bHLH family 
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NeuroD belongs to basic helix-loop-helix transcriptional family, which has over 
240 members to date in various organisms. Their members include Neurogenin, 
NeuroD, Math, Mash, MyoD and so on. Several developmental events such as 
neurogenesis, myogenesis and pancreatic development are dependent on bHLH 
factors (Chae et al., 2004).   
Although numerous studies have revealed transcriptional regulation and 
developmental role of bHLH factors, little is known about post-translational 
modifications they need to undergo to attain full function. From the few reports, we 
summarize that bHLH family members could undergo two kinds of modifications: 
phosphorylation and ubiquitination. Several bHLH factors such as MyoD, Myf5, 
Mash1 and Ngn1 were subjected to phosphorylation and ubiquitin-mediated 
proteolysis (Tintignac et al., 2000; Vinals et al., 2004; Doucet et al., 2005; Vosper et 
al., 2007). Therefore, phosphorylation is a prerequisite for ubiquitination and they are 
continuous processes. Recently, the field of protein modification has attracted 
renewed interests.  
In this study, we demonstrated binding of zPin1 with bHLH family members: 
NeuroD and Ath1. We also characterized the stabilizing effect of zPin1 on NeuroD. 
As such, Pin1 provides a new level of post-phosphorylation modification for the 
regulation of protein functions. Thus, interaction of Pin1 on bHLH factors is novel 
and might represent a universal mechanism for modifying activities and stability of 
bHLH factors, which awaits further verification in furture studies.  
 
4.10 Conclusion  
Pin1, a conserved prolyl isomerase, belongs to PPIase family and is the only 
member to catalyze pSer/Thr-Pro motif. The consequence is to change the 
Discussion and Conclusion 
 127 
conformation of target protein, thereby, affecting protein-protein interaction, 
transcriptional activity and protein stability. The role of Pin1 is widespread and is 
implicated in a variety of biological processes such as cell cycle, immune response 
and neurodegeneration. Accordingly, its deregulation could cause pathogenesis such 
as Alzheimer’s disease, cancer and asthma.  
Although much information was gained from Pin1 knockout mice, the function of 
Pin1 in early development largely remains enigmatic. With the use of zebrafish 
embryos, we attempt to examine zPin1’s effect on early development. Consistent with 
role of mPin1 in regulating Tau and APP in knockout mice, zPin1 loss of function in 
zebrafish also caused neuronal phenotypes, particularly in neuromast cells defects. In 
transgenic ET4 embryos, the neuromasts formation was clearly disrupted in nearly 
90% of Pin1 knockdown embryos. In situ analysis showed that neuroD mRNAs level 
was decreased significantly in zPin1 morphant embryos. Further studies revealed 
interaction between zPin1 and NeuroD and their interaction was dependent on 
multiple phosphorylation sites on NeuroD. In vitro molecular study in cell lines 
showed that zPin1 can stabilize NeuroD, which was the underlying mechanism of 
neuromasts defect. 
These data demonstrate for the first time that zPin1 could interact with proneural 
bHLH factors in a developmental context. In view of Pin1’s diverse effects on its 
targets and renewed interests in protein modification, this work paves a path for future 
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1 Interaction between human Pin1 and zebrafish NeuroD 
It has been revealed that zebrafish Pin1 shares a high similarity (79%) with human 
Pin1. Moreover, we demonstrated that zPin1 could interact with NeuroD and this 
interaction was dependent on NeuroD phosphorylation. This result was the basis for 
all our thesis work. We indicated in the results and discussion part that rescue was 
unsuccessful on zebrafish embryos. Therefore, we had to perform rescue experiment 
on cell lines.  
To evaluate the feasibility of this assay, we used GST human Pin1 beads to 
pulldown cell lysates overexpressing zebrafish NeuroD. The result demonstrated that 
hPin1 could indeed associate with NeuroD (Fig. S.1). Therefore, it is plausible that in 
human HEK 293T cells, the absence of endogenous Pin1 can affect the stability of 
overexpressed NeuroD, which has been confirmed by our stability assay showing that 
loss of Pin1 can stabilize NeuroD. Furthermore, impaired stability of NeuroD can be 
restored by overexpressing zPin1 or hPin1. We could conclude that both hPin1 and 
zPin1 complement the reduced protein stability of NeuroD in 293T Pin1 knockdown 
cells. Rescue experiments were also demonstrated in MEFs cells.  
Indeed, in 1996, Lu et al. revealed that human Pin1 substituted the function of 
ESS1 in yeast. Our study demonstrated that zPin1 compensated the function mouse 
Pin1 and human Pin1 in mouse MEF cells and HEK 293T cells. These results 







2 Detection of one zPin1 gene copy in zebrafish genome 
In Western blotting, we displayed that there seemed to be another isoform of 
zPin1 in muscle. However, with RACE experiment, we only retrieved one zPin1 
sequence.  
To further confirm that there were no zPin1 isoforms in zebrafish, we 
performed Southern blotting experiment. We adopted several restriction enzymes 
(HindIII, EcoRI, XbaI, TaqI) to digest genome. Eventually, only one zPin1 gene 
copy was detected (Fig. S.2).  
  A great number of problems occurred in this assay. Indeed, after being treated 
with enzymes, zebrafish genome should display a stripe of digested fragments 
(HindIII digested products, picture not shown). However, in our hands, one 
distinguished single non-cut band can be viewed on the gel after EcoRI and XbaI 
treatment, which means that they can not digest genome well. Therefore, one 
four-cutter enzyme (TaqI) was utilized and this enzyme can cut genome into 
small pieces. Finally two enzymes (HindIII and TaqI) worked and we detected 
only one zPin1 copy. However, one big problem was the dark background. 
Meanwhile, we did not place marker in this assay. Still, from the band position, 
we can identify that in TaqI digested genome, the band lies lower compared to 
that of HindIII digested genome, confirming the efficiency and specificity of 































           Figure S.1 Interaction between human Pin1 and zebrafish NeuroD. 293T cells 
were transfected with wild type NeuroD, S157A, S259A as well as S267A construct. 
Twenty four hours later, cell lysates were collected and subject to GST-hPin1 beads. 
After incubation for 3 h at 4°C, beads were washed and analyzed by Western 


















                                                               
 
 
Figure S.2 Detection of gene copy numbers in zebrafish genome with Southern 
blotting. Zebrafish genomic DNA was extracted from adult fish. DNA was cut with 
HindIII and TaqI for 6 hours for complete digestion. The digested DNA was probed 

























3 Establishment of ET33-mi20 line 
Tol2 transopon-mediated enhancer trap (ET) technology has become a quite 
effective technology to establish mutant line in zebrafish, for its relatively easy 
insertion analysis, high mutation rate and efficiency (Kawakami et al., 1998; 
Kawakami et al., 1999; Koga et al., 2002).  
An ET construct contains the EGFP gene downstream of a promoter region 
from zebrafish keratin 8 (krt8) gene (Gong et al., 2002). The Tol2 transposable 
element, which was first identified in medaka, contains a truncated transposase 
gene but still possesses the transposition activity. The ET construct was co-
injected with Tol2 transposase mRNA for insertion of ET element into zebrafish 
genome (Kawakami et al., 2000). After screening, about 24 F1 were identified. 
One of them was called ET33, in which, a single Tol2 insertion in the 3’UTR of 
zic6 gene (Parinov et al., 2004).  
Because Tol2 insert could be made to jump to alternative positions simply by 
injecting transposase mRNA into ET lines, a few derivative lines were thus created 
in the hope that some of them will be insertional mutants. One of them, ET33-mi20, 
has Tol2 transposon cassette re-inserted into the first exon of neurogenin1 gene on 
ET33 background (Fig. S.3A). The line can be identified by the presence of 
abnormal posterior line ganglian at 32h (Fig. S.3B, C, D and E). Furthermore, in 
situ hybridization for ngn1 showed that in ET22-mi20, ngn1 transcripts were absent, 
confirming that ngn1 gen was indeed mutated (Fig. S.3F and G).  This line was 
established by Igor Kondrychyn from Dr. Korzh’s lab in IMCB (unpublished paper). 













Figure S.3 Isolation of neurogenin 1 mutant. ET33-mi20 line carries Tol2 insertion 
in the first exon of neurogenin 1 gene. (A) Schematic representation of neurog1 
structure. Transposon is inserted in the first exon coding 5’UTR. Direction of gfp 
transcription (green arrow) and sequence flanking the insertion site are shown. Start 
codon (ATG) is underlined, transposon 5’-end sequence is indicated in red and intron 
sequence (106 bp) is shown in small letters. Primers used for RT-PCR are shown as 
blue arrows. RT-PCR analysis of neurog1 transcript shows the absence of mRNA in 
mutant. Line 1: neurog1+/+, line 2: neurog1+/-, line 3: neurog1-/-. B-E: Confocal 
images of ET33-mi20 homozygous (B, D) and heterozygous (C, E) embryos. Arrow 









4 Detection of early specification markers 
Before we focused the function of zPin1 on neuromasts hair cells formation, we 
characterized whether the specification of early cells fate was affected.  
We adopted gsc and ntl to stain embryos at 6 hpf. The two markers were well-
characterized and used extensively: gsc stains mesoderm shield area and ntl stains 
early axial mesoderm specifically (Schulte-Merker et al., 1994). Our result 
demonstrated that there was no difference for expression pattern of those two genes, 
which suggested that mesoderm development was not affected (Fig. S.4A, B, C and 
D). Another axial mesoderm marker shh, which was expressed in floor plate and 
notochord, was applied on 18 hpf embryos (Currie et al., 1996; Lawson et al., 2002). 
The staining for wild type and zPin1 morphant was similar, which further confirms 
























Figure S.4 In situ hybridization of early specification markers. Wild type and zPin1 
morphant were collected at 6 hpf (A, B, C, D) or 18 hpf (E, F), respectively. The embryos 
collected at 6 hpf were stained with gsc and ntl. Shh was used to stain the embryos at 18 











5 Endogenous NeuroD pulldown with GST-zPin1 beads 
We demonstrated that zPin1 can pulldown NeuroD. However, in all assays, we 
used cell lystaes overexpressing NeuroD. To confirm the relationship between 
zPin1 and NeuroD, we tried to pull down endogenous NeuroD wih zPin1.  
Firstly, several cell lines were tested for their endogenous NeuroD expression. 
Only SH-SY5Y cells express NeuroD, but only at a low level. With anti-NeuroD 
antibody we detected a single NeuroD protein at about 50 kDa. However, after 
pull down with GST-Pin1, there were several bands around this molecular weight. 
We initially thought these were phosphorylated NeuroD. These bands were 
excised and sent for Mass Spectrometer (MS) analysis. To our disappointment, 
none turned out to be NeuroD (Fig. S.5). The problem was that we can not 
identify which band was really the pulldown NeuroD band. It has been 
demonstrated previously that zPin1-NeuroD interaction was phosphorylation 
dependent. Therefore, it is highly possible that one of those bands that lied higher 
than endogenous NeuroD was indeed phosphorylated NeuroD. Due to time 
constraint and bad quality of NeuroD antibody, we did not continue this assay. In 
the future, it is likely that those bands could be confirmed by repeating the 




































Figure S.5 GST-zPin1 pulldown of endogenous NeuroD. SH-SY5Y cell lysates 
were collected and assayed with NeuroD antibody. The cell lysates were then added 
into GST only beads and GST-zPin1 beads for pulldown assay. The tube was 
incubated at 4°C for 6 hours. The beads were then washed and analyzed with 
Western blotting using NeuroD antibody. No band was detected after pulldown with 
GST beads, in contrast, several bands could be observed for GST-zPin1 pulldown at 
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